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ABSTRACT 
Manganese (Mn) is an essential trace element found in most living organisms. 
Chronic exposure to Mn has been linked to the pathogenesis of manganism, which displays 
neurological abnormalities somewhat similar to those associated with Parkinson's disease 
resulting from dysfunction of the extrapyramidal motor system within the basal ganglia. 
However, the exact cellular and molecular mechanisms underlying Mn induced neurotoxicity 
have not been defined. Oxidative stress mediated dopaminergic neuronal apoptosis is 
considered to be the prime mechanisms of Mn neurotoxicity. Thus, we sought to identify the 
genes that are altered during Mn exposure and that lead us to elucidate the mechanisms 
underlying Mn induced neurotoxicity. First, we used the Qiagen mouse apoptosis RT2 
Profiler™ quantitative PCR array system to identify the genes susceptible to Mn exposure. 
We treated C57 black mice with 10 mg/kg Mn via oral gavage for 30 days. Afterwards, PCR 
apoptosis array was performed on substantia nigral tissues for 84 genes associated with 
apoptotic signaling. Interestingly, we found a significant downregulation of the tumor 
repressor gene p73 in Mn-treated substantia nigral tissues. Western blot analyses revealed 
that the p73 isoform protein lacking transactivation domain at N-terminus (ΔNp73) was 
downregulated from substantia nigral tissues of C57 black mice exposed to 30 mg/kg Mn for 
30 days via gavage. To further characterize the functional role of Mn-induced p73 
downregulation in Mn neurotoxicity, we examined the interrelationships between the effects 
of Mn on p73 gene expression and apoptotic cell death in an N27 dopaminergic neuronal 
model. Mn exposure to 300 μM downregulated ΔNp73 proteins in N27 dopaminergic 
neurons in a time-dependent manner, which consistently supports our animal study. We 
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further determined that protein level of the ∆Np73 was also reduced in primary striatal 
cultures in a dose-dependent manner. Furthermore, overexpression of ∆Np73 conferred 
modest cellular protection against Mn-induced neurotoxicity. Secondly, we identified signal 
transducer and activator of transcription 5b (STAT5B) gene which was downregulated both 
in a time-dependent and dose-dependent manner during Mn exposure in N27 dopaminergic 
neuronal cells over 12 h span. However, STAT1 was relatively unaffected during Mn 
treatment, indicating isoform-specific effect of Mn on STAT5B. Consistent to N27 
dopaminergic neuronal cell model, Mn exposure downregulated STAT5B expression in 
primary mouse striatal culture. Quantitative RT-PCR analyses showed Mn exposure induces 
downregulation of STAT5B expression at the transcriptional level as well. Moreover, Bcl-2, 
a well-known downstream target of STAT5B pathway, was also downregulated 
concomitantly during Mn exposure. Pretreatment of 20 μM Lactacystin failed to protect 
downregulation of STAT5B indicating STAT5B downregulation was independent of 
proteasomal degradation pathway. Pre-treatment of N-Acetyl Cystine (NAC) was shown to 
protect downregulation of STAT5B. In addition, treatment of MPP+ in N27 cells showed 
downregulation of STAT5B. These results support the hypothesis that Mn exposure mediates 
oxidative stress that induces downregulation of STAT5B. Overexpression of STAT5B cells 
protected N27 cells against Mn-induced neurotoxicity. Furthermore, overexpression of 
STAT5B protected mitochondria in N27 cells. Downregulation of STAT5B was 
recapitulated in substnatia nigra of C57 black mice model treated with Mn and MitoPark 
Parkinson’s disesse model. We also present that human lymphocytes show downregulation of 
STAT5B during Mn exposure, proposing a potential drug candidate for Mn-induced 
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neurotoxicity and Parkinson’s disease patients. Furthermore, we show that Mn exposure 
suppresses promoter activity of STAT5B in MN9D dopaminergic cells. To characterize the 
molecular mechanisms underlying STAT5B downregulation during Mn neurotoxicity, we 
examined the effects of 300 μM Mn exposure for the promoter analysis of STAT5B 
expression. We subcloned the STAT5B promoter 1 from mouse brain. Analysis of mouse 
STAT5B promoter from 2,000 nt upstream to 5,00 nt downstream region indicated that a 
proximal region near exon 1 contains the regulatory element in response to Mn exposure. 
Detailed mutational analyses of the putative transcription factor binding site revealed that a 
Sp1 like transcription factor binding sites near exon 1 may be required for the suppression of 
STAT5B in Mn-induced neurotoxicity. Two KLF binding sites exhibited to be transcription 
repressor that can respond to Mn exposure, whereas one Sp1 binding sites exhibited 
transcription activator which senses Mn exposure and reduces its activity. These data suggest 
Mn exposure alters the profiles of transcription factors to downregulate anti-apoptotic 
STAT5B signaling via an Sp1-like transcription factor-dependent mechanism in 
dopaminergic neurons, which may significantly contribute to Mn neurotoxicity. Taken 
together, our results suggest that Mn exposure compromises the expression of 
neuroprotective ΔNp73 and STAT5B in dopaminergic neurons for Mn-induced neurotoxicity, 
thereby exacerbating neuronal cell death (NIH grants ES10586, ES19267, NS74443). 
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CHAPTER I: GENERAL INTRODUCTION 
 
Dissertation Organization 
This dissertation is written in an alternative thesis format and consists of manuscripts 
that are being prepared for submission to scientific research journals. The dissertation 
contains a general introduction, three research papers, a general conclusion that discusses the 
overall findings from all the chapters, and an acknowledgment. The references for each 
individual section are listed at the end of the corresponding chapters, except for the general 
introduction section whose references are listed following the general conclusions. The 
introduction section under chapter I provides a brief overview of Parkinson’s disease, 
manganese, and the research objective. The background and literature review I provides 
background information on Parkinson’s disease. The background and literature review II 
provides background information on manganese, protein kinase C delta, p73, and STAT5B 
with brief overall hypothesis. The manuscript from Chapter 2 was recently submitted to 
Neurotoxicology and in the process of communication. This chapter identified ΔNp73 was 
downregulated during Mn exposure and shown to be neuroprotective. Chapter 3 identified 
signal transducer and activator of transcription (STAT) 5B was downregulated during Mn 
exposure and characterized its downregulation. Chapter 4 studies the mechanisms of how Mn 
exposure induces downregulation of STAT5B. Chapter 3 and 4 are in the process of being 
submitted for publication. This dissertation contains the experimental results obtained by the 
author during his Ph.D. study under the supervision of his major professor Dr. Anumantha G. 
Kanthasamy at Iowa State University. 
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Introduction 
Parkinson’s disease (PD) is a chronic, progressive, neurodegenerative disorder after 
Alzheimer’s disease in US (companies, 2014). In US, about 1 million people were affected 
and it is predicted to double the frequency of PD by 2040 (Kowal et al., 2013). PD was first 
described by James Parkinson in 1817 as the “shaking palsy” as PD patients show movement 
disorders such as bradykinesia (slowness of movement), resting tremor, rigidity and postural 
instability. Pathological hallmarks of PD are the loss of dopaminergic neurons in substantia 
nigra (SN) and Lewy bodies composed of protein aggregates. When PD patients begin to 
show the symptoms of PD, about 50% of dopaminergic neurons in SN and 80 % of striatal 
dopamine have been depleted. Average onset of idiopathic PD is 60 years. There are rare 
occurrences of PD at younger age between 20 to 40 years. Genetic factors play important role 
in early familial PD. Genes associated with PD include α-synuclein, parkin, PINK-1, LRRK2 
and DJ-1 (Kumar et al., 2012, Ben-David and Tu, 2015). However, over 90 % of PD are 
independent of genetic factors. Environmental factors are believed to play important role in 
idiopathic PD such as pesticides, industrial byproducts, and metals (Lai et al., 2002). 
Neurotoxic agent such as MPTP was shown to induce degeneration of dopaminergic neurons 
(Bove et al., 2005). Paraquat has similar chemical structure to MPTP (Yang and Tiffany-
Castiglioni, 2005). Both molecules can easily cross blood-brain barrier and induce 
dopaminergic neuronal degeneration. Currently, there is no cure to PD. The strategy of PD 
medicine is to slow down the progress of PD.  Levodopa, a precursor of dopamine, is the 
golden standard medicine in PD (Clarke, 2004). 
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Manganese (Mn) is a versatile metal used in industry for decades and also an essential 
transition metal in living organisms. However, overexposure to Mn induces chronic, 
progressive neurodegenerative disease named as mangansism. The clinical symptoms of 
manganism are somewhat like that of PD (Farina et al., 2013, Martinez-Finley et al., 2013). 
Pathological features of Mn-induced neurotoxicity include loss of dopaminergic neurons in 
midbrain. Major route of Mn intake is through ingestion and under tight regulation of Mn 
uptake. Inhalation of Mn is another important route for Mn uptake and associated with 
occupational settings such as welders and miners. Overexposure to Mn induces reactive 
oxygen species (ROS) and induces oxidative stress (Erikson et al., 2004, Reaney and Smith, 
2005, BARBUSIŃSKI, 2009). Oxidative stress is under tight regulation. However, 
dysregulated oxidative stress activates microglia which in turn induces inflammation to lead 
neurodegeneration. However, the exact cellular and molecular mechanisms underlying Mn-
induced neurotoxicity remain elusive. Hence, identification of novel key molecules in Mn-
induced neurotoxicity is essential in understanding Mn-induced neurotoxicity and 
development of potential drug. The present studies seek to identify novel key molecules and 
understand the mechanism underling Mn-induced neurotoxicity. 
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Background and Literature Review I 
Parkinson’s disease 
Parkinson’s disease (PD) is chronic progressive neurodegenerative diseases. 
Parkinson’s disease is one of the most common neurodegenerative diseases, second only to 
Alzheimer’s diseases (Nagatsu and 
Sawada, 2006). In US, about 1 
million people were affected and it 
is predicted to double the 
frequency of PD by 2040. The 
prevalence of PD increases to 1% 
to 2% of population for a person 
over age of 65 and to 4% to 5% 
over age of 85, respectively 
(Kowal et al., 2013). Average 
onset of PD is 60 years. However, 
there are rare occurrence of PD at 
younger individuals between 21 
and 40 years. Most PD patients 
experience 5 to 10 years of severe 
motor behavioral disorders. Men 
has higher risk in developing PD than woman (Rubin, 2007). The duration of PD has average 
of 15 years from diagnosis to death (Lees et al., 2009). In 1817, James Parkinson originally 
 
Figure 1. Neuropathology of Parkinson’s Disease. 
This figure is adapted and modified from (Dauer 
and Przedborski, 2003). 
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described PD as “shaking palsy” as the main clinical features in 1817. Tremor is one of main 
clinical features of PD and occurs at rest in the PD patients. When they move voluntarily, 
tremor decreases. PD patients have rigidity and show resistance to passive movement of 
limbs. Slow movement was referred as bradykinesia and impairs the quality of life of PD 
patients as it causes very long time to do in their common lives. Postural or gait instability is 
another features of PD patients. PD patients also show reduction of amplitude of movement 
(hypokinesia) and absence of unconscious normal movement (akinesia) (Dauer and 
Przedborski, 2003). PD patients also have non-motor symptoms which can take place in all 
stages of PD. Prodomal non-motor symptoms include rapid eye-ball movement sleep 
behavior disorder, speech abnormalties, constipation, olfactory dysfunction, depressions, 
gastrointestinal and cognitive deficits. Pathological feature of PD is the loss of dopaminergic 
neurons in substantia nigra (SN) which results in deficiency of dopamine (DA) in striatal 
neurons. When PD patients begin to show signs of PD, there are around 80% depletion of 
striatal dopamine and 50% loss of SN neurons (Cheng et al., 2010). Another hallmark of PD 
is Lewy bodies composed of aggregated α-synuclein and other degradation products (Dauer 
and Przedborski, 2003).  
Hereditary forms of PD showed that several genes were associated with the 
pathogenesis of PD (Dauer and Przedborski, 2003). Several hereditary genes found include 
α-synuclein, LRRK2, Parkin, DJ-1, Uch-L1, and PINK1. However, one genetic studies of PD 
carried out by Tanner group (Tanner et al., 1999) provided uncertainty of the hereditary 
genes as the cause of PD. They examined the incidence of PD in monozygotic and dizygotic 
twins and found indistinguishable concordance rate between monozygotic-dizygotic twins, 
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suggesting lack of genetic influence and strong support of environmental factors in the 
etiology of PD. In fact, the vast majority of PD cases over 90% do not have genetic linkage, 
thus referred as sporadic PD. Several environmental factors were shown to be associated with 
the etiology of PD such as pesticides, herbicides, gasoline additives, industrial contaminants, 
metals, and contaminated drugs (Priyadarshi et al., 2000, Ritz and Yu, 2000, Kitazawa et al., 
2002, Kanthasamy et al., 2006a, Saminathan et al., 2011, Song et al., 2011, Caudle et al., 
2012, van der Mark et al., 2012, Van Maele-Fabry et al., 2012, Ngwa et al., 2014, Charli et 
al., 2015).  
Manganese (Mn) is a transition metal and has been used in industry for decades. 
Environmental exposure to Mn is known to cause manganism which is a chronic, progressive 
and neurodegenerative syndrome somewhat like Parkinson’s disease. The higher incident of 
manganism has been observed in among occupational groups including welders, miners, 
farmers who have been exposed to Mn based fungicides such as Maneb and Mancozeb (Roth, 
2009, Racette et al., 2012, Farina et al., 2013, Michalke and Fernsebner, 2014). The usage of 
drinking waters containing higher level of Mn was reported to have adverse neurological 
effects (Kondakis et al., 1989). Results from several researches suggested that overexposure 
to Mn induces cellular changes including depletion of dopamine, increased oxidative stress, 
and cell death (Kitazawa et al., 2002, Hussain et al., 2006, Fernsebner et al., 2014). However, 
the exact cellular and molecular mechanisms of how Mn exposure induces dopaminergic 
neuronal degeneration remain unclear.  
Unfortunately, there is no known available cure for PD in spite of advancement of 
researches on PD in recent years. Many commercial medicines only alleviate the symptoms 
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of PD. Current golden standard of the PD medicine is levodopa which is a precursor of 
dopamine and produce dopamine in brain (Clarke, 2004). Treatment of levodopa, however, 
gives patients some side effects such as such as nausea and vomiting. Long-term motor 
complications involve abnormal involuntary movements including dyskinesias, dystonia, and 
motor fluctuations. Moreover, the clinical efficacy of treatment of levodopa often declines as 
the PD progresses. Several other approaches to provide PD treatment have been made 
including dopamine agonist, Monoamine oxidasae (MAO) inhibitors, catechol O-
methyltrasnferase (COMT) inhibitors, and nerotrophic factors (Factor et al., 2001, 
Suchowersky et al., 2001, Mandel et al., 2005, Zeng et al., 2006, Schober et al., 2007, Kelley 
et al., 2012). The economical burden of treating PD patients is huge exceeding $14.4 billion 
in US, which is $8.1 billion higher than similar population without PD. As the society will 
have more elderly population in the future, the estimates of medical costs and healthcare bills 
are expected to increase significantly (Kowal et al., 2013).  
In the relatively long history of PD about two centuries, the breakthrough discovery 
was the finding that dopamine (DA) in the mammalian brain. The loss of neurons in 
substantia nigra pars compacta (SNpc) leads the deficiency of DA in the striatal neurons 
which is believed to be the main cause of PD. The finding that the replenishment of DA 
alleviates many symptoms of PD strongly supports the hypothesis. Regardless of PD patients 
whether young onset PD with inheritable genes or sporadic forms of PD, loss of DA in 
striatal neurons and SN leads the PD symptoms. The pathways of dopaminergic neuronal 
system arise from midbrain including SN, hypothalamus, and ventral tegmentum area (VTA) 
(Bjorklund and Dunnett, 2007, Van den Heuvel and Pasterkamp, 2008). Nigral neurons 
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project to the striatum along the nigrostriatal pathway. Briefly, neurons from VTA project to 
limbic and cortical areas along mesolimbic and mesocortical pathways. Nigrostriatal pathway 
consists about 70% of the total dopaminergic neurons in the central nervous system (CNS) 
(Van den Heuvel and Pasterkamp, 2008). Substantia nigra contains very dense population of 
neurons and contains a darker pigment called neuromelanin. Substantia nigra plays important 
roles in receiving neuronal inputs and gives efferent signal to striatal neurons. Loss of 
dopaminergic neurons in nigrostiratal pathway is largely associated with PD because it is 
associated with dorsal sensorimotor striatum.  
 
The Genetics of PD 
Genetic factors can be the causation to PD and has been studied extensively last two 
decades. This familial PD, however, comprises of only 5 to 10 % of the total PD cases. The 
genes identified to have causal effects to PD have been assigned to PARK loci. Genes whose 
mutations have strongly been associated with PD include SNCA, LRRK2, Parkin, PINK1 
(PARK6), PARK1, PARK3, DJ-1 (PARK7), PARK9, PARK10, PARK11, Tau, and Uchl1-1 
(Poulopoulos et al., 2012, Fujioka et al., 2014).    
α-synuclein encodes a small pre-synaptic protein (140 amino acid) from the 
designated gene, SNCA. It is one of the isoform of the synuclein family members 
(Polymeropoulos et al., 1997).  α-synuclein has been found to be one of major component in 
Lewy bodies in PD patient (Spillantini et al., 1997). Mutations of α-synuclein, namely A30P, 
A53T, and E46K have been associated with German, Greek, and Spanish familial PD, 
respectively ((Polymeropoulos et al., 1997, Kruger et al., 1998, Zarranz et al., 2004). These 
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α-synuclein mutant have offered valuable genetic tools to study the genetic model of PD. 
Recently, four additional mutation in SNCA gene (A18T, A29S, H50Q, and G51D) have 
been found (Appel-Cresswell et al., 2013, Hoffman-Zacharska et al., 2013, Lesage et al., 
2013). Although α-synuclein appears to play very important role in pathogenesis of PD, the 
incidence of mutation of SNCA gene is rare. Additionally, genomic multiplication of the 
SNCA gene is present in 1-2% of patients with autosomal dominant PD (Ibanez et al., 2009). 
Triplication of SNCA gene produce double amount of α-synuclein, whereas duplication 
makes 50% more of α-synuclein. Families with duplication of SNCA gene appears to have a 
more damaged brainstem damage and progress with movement disorders (Fuchs et al., 2007). 
In line with finding with genomic multiplication of SNCA, overexpression of α-syuclein was 
Table 1. Genes and Loci associated with parkinsonisma  
 
 
a Adapted and modified from (Martin et al., 2011). 
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shown to induce neurotoxicity with a dopaminergic neuronal loss, which can be rescued with 
overexpression of Rab1 (Cooper et al., 2006).  Increased amount of α-synuclein was shown 
to tend oligomerization (Lee et al., 2002). Dopamierngic neuronal cells with overexpression 
of α-synuclein was showe to be more vulnerable to the exposure to neurotoxic insult of 
dieldrin (Kanthasamy et al., 2005). Although the exact function and role of α-synuclein is 
largely not known, the PD patients with mutations in SNCA genes have clinical and 
pathological features similar to those observed in sporadic PD. They also responded well 
with levodopa treatment. Inclusion of α-synuclein has been found not only in PD but also in 
other neurodegenerative diseases such as Alzeheimer’s disease, Lewy body dementia, and 
multiple system atrophy (Spillantini et al., 1998, Mukaetova-Ladinska et al., 2000, Burn and 
Jaros, 2001). Many mutations of LRRK2 have been associated with families. LRRK2 
mutations show in mid to late onset of PD (Giasson et al., 2006).  The pathology from the 
LRRK2 mutation is very variable giving difficulty in understanding the role of LRRK2 in PD. 
One missense mutation (G2019S) of LRRK2 was shown to increase the kinase activity of 
LRRK2 and alters miR activities to regulate gene expression (Greggio et al., 2008, Gehrke et 
al., 2010). LRRK2 G2019 is relatively common varing between 1% - 40% of PD cases with 
highest frequency in people of North African descent (Ozelius et al., 2006). The patient with 
LRRK2 mutations show high incidence to have Lewy body PD.  
Parkin was autosomal recessive juvenile PD and causes early onset of PD (Kitada et 
al., 1998) accounting for 50% of familial cases with age of onset younger than 20 years 
(Lucking et al., 2000). More than 100 mutations in Parkin have been identified including 
point mutation, deletion, duplication, and exonic rearrangement. The PD patients with Parkin 
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mutation respond well to dopaminergic treatment. Parkin is an E3 ubiquitin ligase and plays 
roles in process of ubiquitination for unnecessary, damage or misfolded proteins (Shimura et 
al., 2000). Parkin also plays a role in the maintenance of mitochondria (Rothfuss et al., 2009). 
 DJ-1 is associated with autosomal recessive early onset PD, accounting for 1 – 2 % 
of early onset PD (Pankratz et al., 2006). DJ-1 gene encodes 189 amino acid protein which 
functions as a cellular sensor for oxidative stress (Junn et al., 2005). The mutation in the DJ-1 
protein causes tendency to misfolded and unstable proteins which gets degraded by 
proteosome (Anderson and Daggett, 2008). Thus DJ-1 mutation reduces the neuroprotective 
potentionals (Malgieri and Eliezer, 2008).  
The phosphatase and tensin homolog (PTEN)-induced putative kinase 1 (PINK1) 
gene is associated with 1% - 9% of early onset PD (Klein et al., 2005, Kumazawa et al., 
2008). Most mutations of PINK1 is missense or nonsense mutation with nearly equal 
frequencies of all 8 exons (Camargos et al., 2009). PINK1 is a 581 amino acid protein and 
ubiquitously expressed. N-terminal domain of PINK1 has mitochondrial targeting motif 
whereas C-terminal domain contains autoregulatory functions. PINK1 and Parkin are found 
to have functions in a common pathway to maintain healthy mitochondria by sensing and 
eliminating damaged mitochondria. Stabilized in a lower membrane potential, PINK1 
recruits Parkin from cytosol which initiate autophagic clearance of damaged mitochondria 
(Narendra and Youle, 2011). 
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Molecular and cellular mechanisms in idiopathic Parkinson’s disease 
The findings of genetic tools and advanced understanding of the genetic models of 
PD have expanded extensively and provided deep insight in understanding partial molecular 
and cellular mechanisms of pathogenesis of PD.  However, the exact molecular and cellular 
mechanisms in understanding the underlying mechanisms of idiopathic Parkinsons’ disease 
have been elusive and remain to be studied extensively largely due to the multiple causations 
to etiopathgenesis of PD. But, recent advancement of studies of PD proposed the oxidative 
stress mediated apoptosis in affected regions in brain is strongly associated with 
 
 
Figure 2. Schematic view of mitochondrial electron transport chain involved 
in oxidative phosphorylation. Adapted and modied from (Keane et al., 2011). 
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etiopathgenesis of PD. Oxidative stress arises from excessive usage of molecular oxygen 
which is required in many cellular reactions for a catalyst and energy production. These 
biochemical reactions using oxygen inevitably produce reactive oxygen speces (ROS) such 
as superoxide anions, hydrogen peroxide, hydroxyl radicals, and peroxy radicals. Besides, 
reactive nitrogen species (RNS) such as peroxynitrite and nitro-tyrosyl radicals can be 
produced from the reactions. Although consumption of oxygen and removal of ROS and 
RNS are tightly regulated, excessive amount of ROS and RNS can be detrimental to cells, 
even to death (Loh et al., 2006, Miller et al., 2009). To cope with negative impacts of ROS 
from usage of oxygen, cells utilize antioxidant enzymes such as catalase, superoxide 
dismutase, and gluthathione peroxidase. Oxidative stress can damage to DNA, protein, and 
lipids, leading to activation of apoptosis (Miller et al., 2009). Post mortem studies 
consistently showed increased oxidation of DNA, protein, and lipids in Alzehimer’s disease, 
Parkinson’s disease, and other neurodegenerative disease such as stroke, Huntington’s 
disease, and amyotrophic lateral sclerosis (Cardoso et al., 2005, Mariani et al., 2005, Moreira 
et al., 2005, Miller et al., 2009, Hwang, 2013).    
Parkinson’s disease patients have multiple sources of oxidative stress from excessive 
usage of dopamine in substantia nigra, genetics factors to environmental factors. Substantia 
nigra contains high density of dopaminergic neurons which oxidize dopamine by monoamine 
superoxide which facilitate the reaction to produce superoxide and hydrogen peroxide 
(Halliwell, 1992). Although DA is contained in vesicles and regulated tightly, excessive DA 
gets oxidized spontaneously or via enzymatic reaction to produce DA quinone. DA quinone 
was shown to modify nucleophiles from nucleic acids and proteins which leads to 
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dysregulate biochemical reactions and pathways to affect cell fates. In addition, DA quinone 
can modify α-synuclein monomer to promote the form of cytotoic protofibril form (Conway 
et al., 2001). DA quinine was shown to inactivate DA transporter and tyrosine hydroxylase, 
which is rate-limiting key enzyme to produce dopamine  (Kuhn et al., 1999). DA quinone can 
induce dysfunction of mitochondria which leading to generate excessive reactive oxygen 
species (ROS) (Van Laar et al., 2009). Mitochondria is another big source to generate 
oxidative stress associated with pathogenesis of PD. Mutations of genes such as parkin, DJ-1, 
and PINK are associated with familial forms of PD (Muftuoglu et al., 2004, Gandhi et al., 
2009, Irrcher et al., 2010). One of the neurotoxicant used to study Parkinson’s disease is 1-
Methyl-4phenyl-1,2,3,6-tetrahydropyridine (MPTP). MPTP was the contaminant in the 
synthetic heroin drug (Schober, 2004, Bove et al., 2005). The drug abusers in 1982 showed 
neurodegenerative disease that resemble the clinical symptoms of PD such as  tremor, 
rigidity, postural instability, bradykinesia (Schober, 2004). Autopsy results of drug abusers 
exhibited degeneration of dopaminergic neurons in SN, except Lewy bodies (Bove et al., 
2005, Landrigan et al., 2005). MPTP is lipophilic molecule and cross blood-brain barrier. 
Monoamine oxidase in astrycyte converts MPTP to MPP+ which is transferred through DA 
transporter and accumulates in mitochondria (Schober, 2004, Uversky, 2004). High level of 
MPP+ in mitochondria inhibits electron transport chain complex I leading to production of 
ROS (Maguire-Zeiss et al., 2005). Excessive ROS in turn triggered cellular apoptosis through 
activation of caspase and DNA fragmentation (Kotake and Ohta, 2003). Paraquat (PQ), 1,1’-
dimethyl-4,4-bipyridinium, is a widely used herbicide with similar chemical structure to 
MPP+ (Chun et al., 2001). PQ can cross blood-brain barrier through neutral amino acid 
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transporter. PQ is selectively accumulated in dopaminergic neurons in SN through DA 
transporter, which produce ROS and leads to cell death (Thiruchelvam et al., 2000, Yang and 
Tiffany-Castiglioni, 2005). These toxicant models have degeneration of mitochondria in 
common which leads to increase of ROS and cell death.  
Microglia are resident immunocompetent cells in brain and one of the four major 
types of cells in CNS  (Mander et al., 2006). The patients of PD have more than six times of 
microglia compared to control group  (McGeer et al., 1988). Microglia responds faster than 
astrocytes and becomes activated in exposure to damaged or infected cells or immune 
mediators such as IL-1β or TNF-α  (Mander et al., 2006). Exposure to MPTP, rotenone, 
manganese (Mn) was shown to induce activation of microglia (Liu, 2006, Zhao et al., 2009). 
Activated microglia can produce superoxide and nitric oxide which contribute to oxidative 
stress (Qian et al., 2010).  
 
Background and Literature Review II 
Manganese 
Manganese was first discovered by Sheele in 1774 and given its name by Guyton de 
Morveau in 1785 to distinguish from magnesium (Inoue and Makita, 1996). Mn is a naturally 
occurring transition metal element from many types of rocks and soils (Williams et al., 
2012b). Mn exists in eleven different oxidation states from minus three to plus seven with 
most common valences being 2+, 4+, and 7+. The versatile chemical properties allow its use for 
many industrial uses as well as important biological elements (Michalke and Fernsebner, 
2014).  
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Manganese exists as a component of various minerals in nature. Most Mn ore are 
consumed in industry to produce ferromanganese which is widely used for the production of 
various steels such as carbon steel, stainless steel, high-temperature steel. Manganese is also 
used for the non-metallic purposes. Manganese dioxide is used for production of dry cell 
batteries, matches, fireworks, and glass-bonding materials. It serves as starting materials for 
other types of manganese compounds. Manganese chloride is used as catalyst in the 
chlorination of organic compounds and as essential manganese suppliers in animal diets. 
Manganese sulfate is used for fertilizers, while potassium permanganate as a disinfectant, 
anti-algal agent and bleaching. Manganese is used for production of street drugs as well. 
Manganese has been used as fuel additives such as MMT for decades to replace tetraethyl 
lead in gasoline. For the medical purpose, mangafodipir trisodium is used for magnetic 
resonance imaging to improve lesion detection of liver and pancreas (Williams et al., 2012b, 
Martinez-Finley et al., 2013).    
 
Manganese exposure 
Exposure of manganese to human is mainly through inhalation and ingestion (Farina 
et al., 2013). Plants such as wheat, rice and tea leaves represent a major source of dietary 
manganese. Drinking water is another major source for manganese intake. Some regions in 
Bangladesh were reported to have as high as 2.4mg-1 of manganese in drinking water (Frisbie 
et al., 2009). Manganese absorbed through gastrointestinal system goes through tight control 
of homeostasis allowing excretion of excessive manganese (Klaassen, 1974).  Inhaled 
exposure to manganese is frequently related to occupational conditions. Norwegian 
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manganese alloy producing industry produced as high as 27 mg Mn m-3 (Ellingsen et al., 
2003). Manganese mining site in Mexico was reported to produce high level of manganese in 
the air. A range of manganese from 0.04 to 5,86 µg Mn m-3 in the air was reported in 2 km 
distance from the site (Rodriguez-Agudelo et al., 2006). Welding operation often produce 
gaseous particle of manganese. Historically, poorly conditioned workplace without proper 
ventilation puts higher level of manganese (Antonini et al., 2006, Flynn and Susi, 2009).  
There are non-occupational sources for manganese exposure to human. Inhalable manganese 
particles are emitted from manganese containing fireworks and abrasion of steel alloys. 
 
 
Figure 3. Mn transport. Adapted and modified from (Martinez-Finley et al., 2013). 
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Combustion of fossil fuels emits manganese 5-300mg Mn kg-1. The environmental source for 
manganese exposure include the gasoline additives, methylcyclopentadienyl manganese 
tricarbonyl (MMT) was reported to produce manganese from 5  to 20mg kg-1 (Pfeifer et al., 
2004), and some pesticide such as maneb and mancozeb (Pennington and Wilson, 1990). The 
use of manganese as medical agents provides another source. Long term parental nutrition 
was reported to induce Hypermanganesemia (Fell et al., 1996). The majority of manganese 
intake is taken orally through gastrointestinal systems. A healthy individual absorbs 3 to 5 % 
of manganese (Davidsson et al., 1989).  In bloodstream manganese is bound mainly to 
transferrin and albumin. Liver is the main organ to eliminate manganese (Madejczyk et al., 
2009). As manganese absorbed through gastrointestinal system is  under tight homeosystem, 
adverse effects of ingestion of excess amount of manganese are seldom reported (Portier, 
2012). Most inhaled manganese gets deposited in the alveolar or pulmonary region of the 
respiratory track (Zimmer and Biswas, 2001). Depending on the degree of solubility of 
manganese aerosol, manganese particulate matter shows different time for its removal 
(Antonini et al., 2006). Manganese small particles gets also deposited in nasal/head airway 
region which provides direct route to deliver manganese to brain by bypassing blood-brain 
barrier (BBB) and homeosystem in liver (Henriksson and Tjalve, 2000). Small size of 
manganese particle is located in very close proximity to alveolar blood vessel and gain direct 
access to blood stream. In physiological condition, manganese tends to bind to carrier 
molecules such as transferin or albumin and get transported to different organs. Molecules 
associated with Mn transport were depicted in Figure 3. The central nervous system, or CNS, 
is a particularly important organ that receives an excessive amount of manganese-induced 
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toxicity. Manganese accumulates in globus pallidus, striatum and the substiantia nigra pas 
compacta (Inoue et al., 1975). Manganese can travel to brain where influx of molecules is 
tightly controlled in blood-brain barrier with the help of ligand. Transferin, divalent metal 
transporter-1 (DMT-1), and citrate were reported to transport manganese (Farina et al., 2013).  
 
Parkinson's disease like manganese-induced neurotoxicity 
Chronic exposure of low level of manganese induce to develop neurotoxicity called 
manganism whose pathological feature is similar to that of parkinson's disease patients 
(Lucchini et al., 2009, Roth, 2009, Guilarte, 2010, 2011, Caudle et al., 2012). Both patients 
exhibited movement disorders such as loss of postural stability, gait disturbance and a 
propensity to fall. Unlike patients of parkinson's disease, manganese exposed patients have 
no response from L-dopa treatment and resting tremor which is important features of 
parkinson's disease. Biochemical research revealed that both patients have low level of 
effects of dopaminergic neurons (Guilarte, 2011). Yet, the pathology of PD is largely 
attributable to the progressive loss of dopaminergic neurons due to the neurodegneration in 
SN and STR. The symptoms of manganisms is more related to degeneration of globus 
pallidus. Manganism patients generally lack Lewy body, a hallmark of PD (Caudle et al., 
2012).  Yet, exposure to Mn was reported to increase the risk of developing PD (Santamaria 
et al., 2007). Fifteen welders were reported to have the onset of PD 17 years earlier (Racette 
et al., 2001). Thus, protection of dopaminergic neurons from neurotoxicity could help both 
patients. 
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Cellular and biochemical changes following manganese exposure 
Manganese preferentially accumulates in mitochondria when cells were exposed to 
manganese. Ca2+ uniporter appears to transport manganese into mitochondria (Gavin et al., 
1999). Mitochondria are the sites where eukaryotic cells generate energy through aerobic 
oxidative metabolism. The greatest amount of ROS is produced from electron transport chain 
(ETC) from mitochondria than other organelles (Martinez-Finley et al., 2013). The 
superoxide formed in mitochondria is converted to hydrogen peroxide and transported to 
other parts of cells including cytosol and nucleus. ROS species can cause damage to nucleic 
acids, proteins, and phospholipids both in mitochondria and cells. Mitochondrial DNA is 
Table 2. Similarities and Diffeences between PD and manganese-induced 
toxicitya
 
a Adapted and modified from (Martinez-Finley et al., 2013). 
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very sensitive to ROS as it does not have protective mechanisms and histones, leading to 
degeneration of mitochondria. Manganese can bind to calcium binding sites in tricarboxylic 
acid (TCA) cycle to increase ATP production which in turn increase ROS production. 
Excessive manganese can inhibit the rate of ATP production through inhibition sites in ETC 
(Gavin et al., 1999). Furthermore ROS can induce to have mitochondrial permeability 
transition (MPT). MPT dissipates electrochemical proton gradient and turns off ATP 
production. MPT plays a component of programmed cell death. The presence of Mn3+ 
induces more reactive oxygen stress leading to disruption of mitochondria and inducing 
apoptosis, a programmed cell death (Reaney and Smith, 2005).  
The exact cellular and molecular mechanisms of dopaminergic neuronal cell death 
upon manganese exposure are still unclear. Recently, our lab demonstrated that neuronal 
cells after manganese exposure undergoes programmed cell death. ROS induced by 
manganese exposure initiates mitochondria related apoptotic process. Cytochrome C release, 
activation of caspase-3, and DNA fragmentation were reported in Mn induced neurotoxicity. 
Protein kinase C delta (PKCδ) was identified as one of the key elements in apoptotic process 
during manganese induced neurotoxicity (Latchoumycandane et al., 2005a, Zhang et al., 
2007a). PKCδ was cleaved proteolytically by active caspase-3. The catalytic domain of 
PKCδ gets released from regulatory domain and activated by phosphorylation, leading to cell 
death. Prevention of activation of PKCδ reduced cell death during manganese exposure 
(Kanthasamy et al., 2003, Kitazawa et al., 2005, Latchoumycandane et al., 2005b). 
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Protein kinase C delta 
 Protein kinase C delta (PKCδ) was first identified by Gschwendt and was cloned from 
a rat brain cDNA library (Gschwendt et al., 1986, Gschwendt, 1999). Protein kinase C delta 
is located in chromosome 3 for human, chromosome 14 for mouse, and chromosome 16 for 
rat (Gschwendt, 1999). Based on the activation patterns, isoforms of PKCδ are classified into 
three groups: conventional PKC (cPKC), novel PKC  (nPKC), and atypical PKC (aPKC) 
(Gschwendt, 1999). PKCd belongs to nPKC and is independent on intracellular calcium 
concentration, while it is activated by diacylgycerol or phorbol ester. cPKC is dependent on 
intracellular calcium concentration, whereas aPKCs are not only independent on calcium but 
also not activated by phsopholipids. PKCδ has N-terminal regulator domain and C-terminal 
catalytic domain which are connected by variable region (Kanthasamy et al., 2003).  
 PKCδ is ubiquitously expressed in many tissues including brain (Leibersperger et al., 
1991). Our laboratory group previously showed that PKCδ is highly expressed in substantia 
nigra and striatum compared to other regions in mouse brain (Zhang et al., 2007b). PKCδ can 
 
Figure 4. The structural and functional features of PKCd. Adapded and modified 
from (Kanthasamy et al., 2003). 
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be activated by phospholipid such as diacylglycerol and by tyrosine phosphorylation. In 
addition, PKCδ can be activated via cleavage of PKCδ by proteolytic activation of Casp-3. 
Once activated, PKCδ translocates to the cell membrane or other subcellular organelles. Thr-
505, Ser-643, and Ser-662 were identified as key phosphorylation sites in PKCδ 
(Kanthasamy et al., 2003). Phosphorylation of Thr/Ser in PKCδ influences the kinase activity 
of PKCδ (Le Good et al., 1998). PKCδ was shown to be activated in nonneuronal cell types 
in response to various apoptotic stimuli, including tumor necrosis factor-α (TNFα), Fas 
 
 
Figure 5. Shematic representation of the proapoptotic role of PKCd in oxidative 
stress induced apoptosis. Adapted and modified from (Kanthasamy et al., 2003) 
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ligand, and Interleukin-1β (Kanthasamy et al., 2003). Our group previously also showed that 
dopaminergic neurotoxic agents can activate PKCδ via Casp-3 mediated cleavage 
(Anantharam et al., 2002, Kitazawa et al., 2003, Yang et al., 2004). Active caspase-3 induces 
proteolytic cleavage of PKCd to yield 38 kDa of regulatory and 41 kDa of catalytic domain. 
Furthermore, prevention of cleavage of PKCδ with pretreatment of caspase-3 inhibitor was 
shown to protect dopaminergic neuronal cells (Kanthasamy et al., 2006b). PKCd is a key 
protein that mediates the upstream apoptotic signal to arrays of executing pathways in 
manganese induced neurotoxixity as well as in PD. Though PKCd offers great potential to 
new pharmaceutical drug candidate and good understanding of neurotoxicant induced 
dopaminergic neurodegeneration, much gap still needs to fill in to elucidate pathogenesis of 
PD and manganese induced neurodegeneration. 
 
p73   
Human p73 gene was identified in 1997 in chromosome 1p36. The p73 gene (also 
known as Trp73) is a homolog together with p63 to p53 tumor suppressor gene which share 
similar domain architecture within all three gene family. Alternative splicing produces 
multiple mRNA transcripts which differ at C-terminus of three genes. The p73gene has 15 
exons and two different transcription start sites. Additionally, the presence of transactivation 
(TA) domain adds more diversity in isoforms of the p73 transcription, as transcripts from the 
upstream promoter generate transactivation domain-containing isoforms of p73 (TAp73), 
while transcripts from the second promoter produce the N-terminal transactivation domain-
truncated isoform subfamily (∆Np73). p53 family genes including p73 play key roles in 
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regulators of proliferation, differentiation, cell death, and stem cell renewal. Besides, p53 and 
p73 are also implicated in neurodegenerative diseases such as Alzheimer's disease (Yang et 
al., 2002, Vousden and Lane, 2007, Killick et al., 2011, Engelmann et al., 2015). Similar to 
the p53 tumor suppressor, TAp73 induces apoptosis and serves as a tumor suppressor. 
Interestingly, ∆Np73 inhibits cellular apoptosis by directly inhibiting TAp73 activity 
(Nakagawa et al., 2002, Dobbelstein et al., 2005, Killick et al., 2011). Although the p53 
family members, including p73, share highly similar protein architectures and cellular targets, 
they have different upstream signals (Rosenbluth and Pietenpol, 2008).  
Both TAp73 and ΔNp73 express in various cancers including bladder, breast, colon, 
and neuroblastoma (Engelmann et al., 2015). Main function of TAp73 in cancer is to inhibit 
cell cycle progression, maintenance of genome stability and promotion of apoptotic cell 
death. TAp73 transcriptionally activate the targets of p53 such as p21 or GADD45 and 
mediates cell cycle arrest in G1 and G2/M. Genotoxic or oncogenic stress mediates TAp73 to 
promote mitochondria-mediated apoptosis by activating Bax, Puma, Noxa, Bad, Bik, and 
p53Aip1 which are targets of p53. In addition, TAp73 induces p53-independent 
mitochondrial apoptosis by transcriptionally activating GRAMD4. TAp73 also induces 
activation of pro-apoptotic signal cascade. IGFBP3 is a target of TAp73 and induces cancer 
cell death. Interleukin 4 (IL-4) receptor is another target of TAp73 and mediates IL4-
mediated cell death. TAp73 is also implicated in autophage-mediated cell death. Both TAp73 
and ΔNp73 gene products are regulated by ubiquitine-proteosomal degradation pathway. 
Interestingly, TAp73 responds to DNA damage and transcriptionally activate ring finger 
domain ubiquitin ligase, PIR2, which binds to TAp73 and ΔNp73. PIR2 stabilizes TAp73, 
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however, degrades ΔNp73 through ubiquitination, increasing the ratio of TAp73 over ΔNp73. 
Genotoxic stress also induces AP-1 transcription factor which suppress transactivation of the 
polyamine catabolic enzyme PAOX. Antizyme AZ1 was induced by polyamines and 
mediates degradation of ΔNp73.  
p73 gene products participate in playing roles in development of neurons. Unlike p53 
knockout mice, p73 knockout mice do not develop tumors. However, p73 knockout mice 
have developmental defects in CNS including congenital hydrocephalus and hippocampa 
dysgenesis. P73 knockout mice also showed defect in embryonal and adult neurogenesis. The 
function of p73 gene related to neuronal cell survival was attributed from the loss of ΔNp73.  
p73 gene was also implicated in neurodegeneration. Heterozygous p73+/- mice 
showed substantial increases in tau phosphorylation levels with filamentous aggregates 
 
Figure 6. p73 gene structure and its splicing variants. Adapted and modified 
from (Killick et al., 2011). 
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(Engelmann et al., 2015). It was proposed that ΔNp73 bind and inhibit JNK which directly 
targets tau, while TAp73 cannot. Thus, loss of ΔNp73 impacts on regulation of tau and 
contributes to Alzheimer’s disease. TAp73 might have a role in regulating expression of 
tyrosine hydroxylase (TH), a key enzyme to produce dopamine. The promoter of TH has 
putative p73 binding site. TAp73 was shown to induce expression of TH in in vitro model 
(Grespi and Melino, 2012). However, these findings is needed to confirm in other in vitro 
model as well as in in vivo model.  
 
Signal transducer and activator of transduction 
Signal transduction and activated transducer (STAT) is a molecule that transduces 
many extracellular biological signals to nucleus to regulate specific gene regulation 
(Buitenhuis et al., 2004, Paukku and Silvennoinen, 2004, Abroun et al., 2015). STAT has 
seven family members and share high structural homology. Activation of STATs begins with 
ligands binding to their receptors in cell membrane, leading to activation of Janus-kinase 
(JAK) by phosphorylation. Activated Jak recruits, allows formation of hetero- or homo-
dimerization of proximal STATs before activation by phosphorylation. The phosphorylated 
STATs translocate to nucleus where the extracellular signaling exerts fine and specific gene 
regulation (Paukku and Silvennoinen, 2004, Tan and Nevalainen, 2008).  
The DNA-binding domain has b-sheet structure and recognize GAS element. The 
SH2 domain is highly conserved and play a role in dimerization with other STAT. STATs 
can form homodimers and  heterodimers with other STAT, except STAT5. Transactivation 
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domain at C-terminus is poorly conserved and contains serine residues. Phosphorylation of 
serine residue modulate transcriptional acitivity of STATs (Decker and Kovarik, 2000).  
The function of STAT1 is associated with interferon (IFN). IFN induces a homodimer 
of STAT1 and leading to gene expression of γ-activated sequence (GAS)-driven genes. IFNα 
and β induce STAT1 homodimer or STAT1-STAT2 heterodimer. STAT1 KO mice exhibit 
defective in innate response to viral and bacterial pathogens. STAT1 is considered 
 
Figure 7. STAT structure. Adapded and modified from (Paukku and Silvennoinen, 
2004). 
29 
 
as tumor suppressor as STAT1 KO mice developed tumors more readily than wild type 
(Durbin et al., 1996). STAT1 is also associated with proteins involved in antigen presentation 
(Schindler and Strehlow, 2000). STAT2 is associated with the function of IFNα and IFNβ. 
STAT2 KO mice were susceptible to viral infection due to impaired IFN functions. STAT3 is 
biquitously expressed in most tissues and its function is dependent on tissue types. STAT3 
responds to IL-6 and other cytokines. STAT3 has function of proliferation in many cell types 
 
Figure 8. Schematic diagram of STAT5 pathway.  Adapted and modified from 
(Buitenhuis et al., 2004). 
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including cancer cell line and tumors. STAT4 is expressed selectively in natural killer cells, 
dendritic cells and T-lymphocytes. STAT4 can be activated by IL-12 and plays a role in 
development of Th1 cells. STAT6 is expressed in all tissues. STAT6 is associated with Th2 
differentiation and involved in adaptive immune system. STAT6 is activated by IL-13 and 
often functions with IL-4. STAT6 KO mice exhibits the loss of response to IL-4.  
STAT5 was initially discovered as mouse mammary gland factor before renamed as 
STAT5 because of significant sequence homology with other member of STATs before 
finding of another member similar to STAT5. STAT5A and STAT5B are located on 
chromosome 17 in human and chromosome 11 in mouse. STAT5A and 
STAT5B have high sequence homology over 90% with main difference of sequence in C-
terminal where transcription activation domain is located. STAT5B promoter does not have 
TATA or CAAT box. Instead, STAT5B contains Sp1 sites which were negatively regulated 
by methylation (Crispi et al., 2004). STAT5A KO mice showed loss of response to prolactine 
(PRL) and impairment of mammary gland development. STAT5B KO mice showed lack of 
response to growth hormone (GH) and impairment to growth. Decreased expression of 
STAT5B has also been shown to compromise cellular protection against reactive oxygen 
species (ROS) in peripheral system (Du et al.). Although STAT5 A/B KO mice is viable, 
Table 3. Characteristics of STAT5 a 
 
a Adapted and modified from (Abroun et al., 2015). 
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STAT5 A/B KO mice showed defective mammary gland and reduced body mass with 
defective T-cell proliferation (Liu et al., 1997, Teglund et al., 1998, Miyoshi et al., 2001). 
Though STAT5A and STAT5B share their target genes, they have distinctive roles in various 
conditions. They have non-redundant target gene, different profiles of interactions with other 
co-factors, and different cell types-specific expression profiles (Tan and Nevalainen, 2008, 
Kanai et al., 2014). While many tissues have equal expressions of STAT5A and STAT5B, 
some tissues have more preferential expression of either form. STAT5A is more prevalent in 
mammary gland, while STAT5B is more abundant in liver and muscle. Bain showed more 
expression of STAT5B (Liu et al., 1995). 
STAT5 can be activated by several ways. Cytokine can bind to its receptor and 
trigger activation of STAT5B via JAKs. Known cytokines to activate STAT5 are listed: LIF, 
 
Figure 9. Structural functional domain of STAT5. Adapted and modified from (Tan and 
Nevalainen, 2008). 
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Leptin, IL-3, IL-4, IL-7, IL-10, IL-13, IL-21, IL-22, IL-27, GM-CSF, Epo, IFNα, IFNβ, EGF 
and PDGF (http://www.cellsignal.com/common/content/content.jsp?id=science-tables-jak-
STAT). In addition to cytokine receptors which rely on JAK to activate STAT due to the lack 
of cytoplasmic kinase domain, some tumors constitutively activates tyrosine kinases 
including JAK1, JAK2 and TYK2 (Abroun et al., 2015). Receptor tyrosine kinases such as 
Fyn were shown to activate STAT5 as well (Pullen et al., 2012). STAT can also be 
negatively regulated. Phospho tyrosine phosphatase 1B was shown to de-activate STAT5 
(Aoki and Matsuda, 2000). Suppressors of cytokine signaling were shown to negatively 
regulate STAT (Zhang et al., 1999). It was reported that STAT5 can be negatively regulated 
via proteasomal degradation pathway (Wang et al., 2000). However, recent follow-up studies 
Table 4. Targets of human STAT5 a 
 
a Adapted and modified from (Abroun et al., 2015). 
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showed that there was mishap during experiments (Ramos et al., 2007). In addition, 
transcription factors such as NF-kB was shown to negatively regulate the function of STAT5 
(Geymayer and Doppler, 2000). Moreover, miRNA was also shown to involve regulation of 
STAT5. miR200a was shown to negatively regulate STAT5 expression during pregnancy 
(Williams et al., 2012a). 
As described above, STAT5 has functions related with mammary gland and growth 
hormone related response. The patients with missense mutation in STAT5B exhibited 
retardation in growth and severe immunodeficiency (Kanai et al., 2012). STAT5 is 
implicated in multiple cancers (Tan and Nevalainen, 2008, Wagner and Schmidt, 2011). 
Often times STAT5 pathway was constitutively activated. STAT5B was reported to have 
non-canonical functions. STAT5B was shown to be implicated with structural function in 
Golgi apparatus and endoplasmic reticulum (Sehgal, 2013). Furthermore, STAT5 was shown 
to play a role in mitochondria (Meier and Larner, 2014). STAT5B was translocated in 
mitochondria after IL-3 stimulation (Chueh et al., 2010) and associated with pyruvate 
dehydrogenase complex-E2 (Chueh et al., 2011). STAT5 was shown to bind to D-loop in 
mitochondrial genome (Chueh et al., 2010).  
 
Overarching hypotheses and rationale for these studies 
As described above chronic exposure to low level of Mn induces neurodegeneration 
and show Parkinson’s like symptoms. Recent research extensively studied and identified 
several key molecules such as PKCd, Caspase-3 and p53 (Latchoumycandane et al., 2005b, 
Zhang et al., 2007b, Jin et al., 2011, Uchida et al., 2012, Jin et al., 2014, Wan et al., 2014, Ma 
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et al., 2015). Nonetheless, the exact molecular and cellular mechanisms underlying Mn-
induced neurotoxicity have not been elucidated. Hence, identifying the key molecules in Mn-
induced neurotoxicity is essentially required. The present studies seek to identify the key 
molecules and understand molecular mechanisms of the molecules in Mn-indueced 
neurotoxicity. 
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Abstract 
Chronic exposure to elevated levels of manganese (Mn) has been linked to a 
Parkinsonian-like movement disorder, resulting from dysfunction of the extrapyramidal 
motor system within the basal ganglia. However, the exact cellular and molecular 
mechanisms of Mn-induced neurotoxicity remain elusive. We treated C57 black mice with 
30 mg/kg Mn via oral gavage for 30 days. Interestingly, we found a significant 
downregulation of the truncated isoform of p73 protein at N-terminus from nigral tissues of 
Mn-exposed mice. To further determine the functional role of Mn-induced p73 
downregulation in Mn neurotoxicity, we examined the interrelationship between the effect of 
Mn onp73gene expression and apoptotic cell death in an N27 dopaminergic neuronal model. 
Consistent with our animal study, a 300μMMn treatment significantly suppressed p73mRNA 
expression in N27dopaminergic cells. We further determined that protein levels of the∆Np73 
isoform with truncated transactivation domain at N-terminus was also reduced in Mn-treated 
N27 cells and primary striatal cultures. Furthermore, overexpression of ∆Np73 confers 
modest cellular protection against Mn-induced neurotoxicity. Taken together, our results 
demonstrate that Mn exposure downregulates p73 gene expression resulting in enhanced 
susceptibility to apoptotic cell death. Thus, further characterization of the cellular mechanism 
underlying p73 gene downregulation will improve our understanding of the molecular 
underpinnings of Mn neurotoxicity. 
 
Keywords: Manganese, p73, neurotoxicity, ∆Np73 
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1. Introduction 
Neurodegenerative diseases are becoming more prevalent due to aging populations, 
genetic alterations, and exposure to an increasing array of environmental toxicants such as 
pesticides, neurotoxic metals and industrial byproducts (Caudle et al., 2012, Kanthasamy et 
al., 2012, Goldman, 2014, White et al., 2015). The transition metal manganese (Mn) is an 
essential trace nutrient that not only serves as a co-factor for a variety of enzymes including 
superoxide dismutase 2 and glutamine synthetase, but is also important for various normal 
physiological functions including bone formation, fat and carbohydrate metabolism, as well 
as the regulation of blood sugar, cellular energy, the immune system and calcium absorption 
(Aschner et al., 2009). Mn has been used widely in various industries for more than two 
centuries. The primary routes of Mn exposure are inhalation in occupational settings and 
dietary consumption in general. Airborne Mn particles from various chemicals including 
methylcyclopentadienyl manganese tricarbonyl (MMT) and fungicide are another important 
source of public exposure (Bowman et al., 2011, Caudle et al., 2012). Mn overexposure 
causes a neurodegenerative disorder known as manganism. Many clinical symptoms of 
manganism are also seen in PD patients, including gait dysfunction, postural instability, 
bradykinesia, rigidity and a mask-like face expression (Guilarte, 2011). Pathologically, both 
manganism and PD show dopaminergic neuronal cell death in the substantia nigra (SN) and 
striatum (STR). But unlike PD, manganism is unresponsive to L-dopa therapy and develops 
psychological abnormalities in its early phase.  
The p73 gene (also known as Trp73) belongs to the p53 tumor suppressor gene family, 
and like other family members, codes for multiple mRNA transcripts (Rosenbluth and 
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Pietenpol, 2008). Besides playing an important role in regulating differentiation, cell death, 
and neural stem cells, p73 is also implicated in neurodegenerative diseases such as 
Alzheimer's disease (Yang et al., 2002, Killick et al., 2011, Engelmann et al., 2015).The 
p73gene has 15 exons and two different transcription start sites. The C-terminal domain of 
p73 is alternatively spliced generating a variety of isoforms. Transcripts from the upstream 
promoter generate transactivation domain-containing isoforms of p73 (TAp73), while 
transcripts from the second promoter produce the N-terminal transactivation domain-
truncated isoform subfamily (∆Np73). Similar to the p53 tumor suppressor, TAp73 induces 
apoptosis and serves as a tumor suppressor. Interestingly, ∆Np73 inhibits cellular apoptosis 
by directly inhibiting TAp73 activity (Nakagawa et al., 2002). The p53 family members, 
including p73, share highly similar protein architectures and cellular targets, but they have 
different upstream signals (Rosenbluth and Pietenpol, 2008). 
Manganese-induced neurotoxicity has been studied extensively, and several key 
players, such as protein kinase C delta (PKCδ) (Latchoumycandane et al., 2005, Jin et al., 
2011),SLC30A10 (Leyva-Illades et al., 2014, Chen et al., 2015), ATM-p53 (Tidball et al., 
2015), and others (Horning et al., 2015) have been identified. However, the cellular and 
molecular mechanisms underlying Mn-induced neurotoxicity still have not been delineated. 
Here, we report that ∆Np73 expression was downregulated during Mn exposure in N27 
dopaminergic neuronal cells, mouse primary striatal cells, and in the mouse SN. Through 
functional studies, we identified that ∆Np73 downregulation makes neuronal cells more 
susceptible to Mn Neurotoxicity. Overexpression of ∆Np73 protects N27 dopaminergic 
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neuronal cells from Mn-induced neurotoxicity. These observations provide new insights into 
the mechanisms underlying Mn-induced dopaminergic neurotoxicity.  
 
2. Materials and Methods 
2.1 Chemicals 
Manganese chloride (MnCl2, 99%) was purchased from Sigma-Aldrich (St. Louis, 
MO). Antibodies against Bcl-xL, Mcl-1, and TAp73were purchased from Santa Cruz 
Biotechnology (Santa Cruz, CA). Monoclonal antibody against ∆Np73 was purchased from 
Imagnex (San Diego, CA).Bradford protein assay kit was purchased from Bio-Rad 
Laboratories (Hercules, CA). Mouse and rabbit monoclonal antibodies against β-Actin were 
purchased from Sigma-Aldrich. The anti-mouse and anti-rabbit secondary antibodies (Alexa 
Fluor 680 conjugated anti-mouse IgG and IRDye800 conjugated anti-rabbit IgG) were 
purchased from Life Technologies (Grand Island, NY) and Rockland (Gilbertsville, PA), 
respectively. RPMI1640, fetal bovine serum, L-glutamine, penicillin, and streptomycin were 
purchased from Life Technologies. We purchased the tetrapeptide caspase-3 inhibitor 
zDEVD-fmk from ApexBio (Houston, TX). 
2.2 Animal studies 
Six- to eight-week-old male C57BL/6J mice were housed at RT under a 12 h light 
cycle with water and food provided ad libitum. Mn (10 or 30mg/kg) was orally administered 
once daily for 30 days. Animals were cared for in accordance with Institutional Animal Care 
and Use committee guidelines. After the treatment period, striatal tissues were collected for 
apoptosis PCR array analysis or for measuring the expression of proteins of interest.  
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2.3 Cell cultures 
A rat-derived dopaminergic neuronal cell line, N27, was kindly gifted from Dr. Kedar 
N. Prasad (University of Colorado Health Sciences Center, Denver, CO). N27 cells were 
maintained in RPMI 1640 media supplemented with 10% fetal bovine serum, 2 mM L-
glutamine, 50 units of penicillin, and 50 µg/ml of streptomycin in a humidified incubator 
with 5% CO2 at 37°C as described previously (Jin et al., 2011). 
2.4 Primary striatal cultures and treatment 
Primary striatal neuronal cultures were prepared from the ganglionic eminences of 
gestational 14- to 15-day-old mouse embryos as previously described (Jin et al., 2011). 
Briefly, after extracting the embryonic brain, the embryonic cerebral cortex was folded away 
to expose ganglionic eminences followed by dissection of the STR, which were then washed 
in Dulbecco's modified eagle media (DMEM) and dissociated via trypsinization. Dissociated 
cells were seeded into poly-D-lysine-coated plates and maintained in Neurobasal medium 
supplemented with B-27 supplements, 500mM L-glutamine, 100 IU/ml penicillin, and 
100µg/ml streptomycin in a humidified incubator with 5% CO2 at 37°C. Four- to six-day-old 
primary striatal neuronal cells were exposed to various concentrations of Mn (100-500 μM) 
for 24 h and then subjected to Western blot analysis. 
2.5 Plasmid constructs 
The expression plasmid for the human p73 alpha isoform (HA-p73alpha-pcDNA3) 
was obtained from Addgene (ID 22102) as described (Jost et al., 1997). To generate the 
expression vector for the N-terminal transactivation domain-truncated p73isoform, the 
appropriate cDNA fragment was PCR-generated fromHA-p73alpha-pcDNA3 using a 
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forward primer, 5'-
CAGATTACGCTAGCTGCTGTACGTCGGTGACCCCGCACGGCACCTCGCCACGGC
CCAGTTCAATCTGCTGAGCAGCACC-3', and the SP6 reverse primer. The restriction 
enzymes of NheI and Xho I were used to generate the5' overhang cleavage site, which was 
used for the ligation reaction with pcDNA3 vector. The resulting clone for ∆Np73 was 
confirmed by sequencing. 
2.6 Transfections 
N27 cells were transfected with ∆Np73DNA construct through electroporation. The 
Amaxa Nucleofector instrument was used according to the manufacturer's protocol. Five 
million cells were transfected with 10µg of plasmids using the A-23 program. Transfected 
cells were seeded in either T-75 flasks or 96-well plates as desired for 24h before treatment 
(Zhang et al., 2007b). 
2.7 Cell viability assays 
Colorimetric MTS assay was performed to measure cell viability using the Cell Titer 
96 Aqueous One Solution Proliferation Assay kit from Promega as described previously (Jin 
et al., 2014a). Briefly, cells were seeded in 96-well plates before exposure to Mn. At the end 
of treatment, 20% MTS reagent was added to each well. The MTS tetrazolium compound is 
bio-reduced in living cells to its colored formazan products. After incubating for up to one 
hour, absorbance at 490nm was measured using a SpectraMax spectrophotometric microplate 
reader (Molecular Devices). 
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2.8 Quantitative real-time RT-PCR 
After treatment, total RNA was extracted from cells using the Absolutely RNA 
Miniprep kit and converted to cDNA using the High Capacity cDNA Synthesis kit (Life 
Technologies). SYBR Green quantitative PCR was performed according to the 
manufacturer’s protocol. Forward primer (5'-ACTGCAAGTCCCGTAAGCAG-3') and 
reverse primer (5'-CATGAGCGACTTCCCTTCAG-3') were used for detecting p73 mRNA. 
Validated primers for 18S rRNA (Qiagen, #PPR57734E) were used as the housekeeping 
gene controls. The threshold cycle (Ct) was calculated from the instrument software, and fold 
change in gene expression was calculated using the ∆∆Ct method. 
2.9 Behavioral measurements 
Spontaneous exploratory movements of mice were measured using a computer-
controlled open-field apparatus (VersaMax animal activity monitor, model RXYZCM-16, 
Accuscan, Columbus, OH) as described previously (Zhang et al., 2007a).The transparent 
activity chamber was 20 × 20 × 30.5 cm and was covered with a transparent ventilated lid. 
Data were collected and analyzed by a VersaMax analyzer (model CDA-8, AccuScan). 
Following a 2-min adaptation period, each mouse was given 10 min to explore the open-field 
monitor while horizontal and vertical movements were recorded automatically via an array of 
infra-red beams. 
2.10 Western blotting 
Cells were lysed in lysis buffer (1% Triton X-100, 1mM EDTA, 100mM NaCl, 1mM 
EGTA, 1mM NaF, 20mM Na4P2O7, 2mM Na3VO4, 10% glycerol, 0.1% SDS, 0.5% 
deoxycholate, 50mM Tris-Cl, pH7.4). Brain homogenates were prepared as described 
43 
 
previously (Jin et al., 2011).Western blotting was performed as described previously (Jin et 
al., 2014b). Briefly, the samples containing equal amounts of proteins were fractionated 
through a 10-15% SDS-PAGE gel and transferred onto a nitrocellulose membrane. Primary 
antibodies against specific proteins were incubated with the membrane. After thoroughly 
rinsing in PBS supplemented with 0.1% Tween-20, the membrane was incubated with Alexa 
Fluor 680 goat anti-mouse, Alexa Fluor 680 donkey anti-goat, or IRDye 800 donkey anti-
rabbit secondary antibodies. For the loading control, β-Actin antibody was used. Immunoblot 
imaging was performed with an Odyssey Infrared Imaging system (LI-COR, Lincoln, NE, 
USA). ImageJ software (National Institutes of Health, Bethesda MD, USA) was used to 
quantify Western blot bands.  
2.11 Statistical analysis 
Data were analyzed using Prism 4.0 (GraphPad Software, San Diego, CA). Tukey's 
multiple comparison test was used after ANOVA for comparing differences between 
multiple groups. Paired student's t-test was used when two groups were being compared. 
Differences were considered statistically significant for p-values <0.05. Data are represented 
as the mean ± S.E.M. of at least two separate experiments performed at least in triplicate. 
 
3. Results 
3.1 Manganese exposure alters apoptosis-related gene expression in mouse substantia 
nigra 
Chronic Mn exposure induces a neurotoxic response in the nigrostriatal system of the 
basal ganglia (Latchoumycandane et al., 2005, Zhang et al., 2007b, Farina et al., 2013, 
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Martinez-Finley et al., 2013). The tumor suppressor p73 gene encodes two major groups of 
p73 isoforms with opposing cellular functions. The full-length p73 protein (TAp73) is known 
to induce apoptosis, while its truncated isoforms (∆Np73) lacking the N-terminal domain 
exert anti-apoptotic activity (Muller et al., 2005, Ozaki et al., 2005, Killick et al., 2011). To 
investigate whether Mn exposure has any effect on the expression of p73 genes in 
vivo,C57BL mice were orally treated with 30 mg/kg/day of Mn for 30 days and then their 
nigral tissues were subjected to biochemical analysis. To perform isoform specific gene 
expression analyses of p73 gene products, we used two specific antibodies directed against 
full-length and truncated p73 proteins, respectively. Interestingly, expression of ∆Np73 in 
Mn-treated mice was reduced by more than 50% when compared to control mice (Fig. 1C-D). 
Full length p73 protein expression was not changed (data not shown). Behavioral 
performance testing also confirmed that 30 mg/kg Mn treatment caused significant motor 
deficits (Fig. 1A-B). These findings in an animal model indicate that Mn exposure induced 
downregulation of ΔNp73 expression. 
 
3.2 Manganese exposure downregulates ∆Np73 expression in N27 dopaminergic cells 
and mouse primary striatal cultures 
To further characterize the downregulation of p73 gene expression and its function during 
Mn exposure, we used the in vitro N27 dopaminergic neuronal cell system. N27 cells were 
exposed to 300 µM Mn. The quantitative RT-PCR analysis was performed for p73 gene 
expression (Fig. 2A). We found ~60% reduction of p73 gene expression relative to control 
cells. Since p73 gene function is not known in Mn neurotoxicity, we characterized the role of 
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p73 using cell culture models. The expression of p73 was analyzed by Western blot assay 
using specific antibody directed against truncated p73 proteins. The truncated isoform of p73 
gene product was downregulated upon exposure to 300 µM in a time-dependent manner with 
~60% reduction relative to control cells at 24 h treatment (Fig. 2B-C), which validated the 
results from our in vivo model and also showed that Mn exposure affected dopaminergic 
neurons and downregulated expression of ΔNp73 in dopaminergic neurons. N27 cells treated 
with 300 µM Mn for 12hdid not trigger cell death, indicating downregulation of ∆Np73 takes 
place prior to cell death. To further validate the Mn-induced downregulation of ∆Np73, we 
showed that in mouse primary striatal cultures exposed to increasing concentrations of Mn 
(100-500 µM) for 24 h, the expression of ∆Np73 was dose-dependently repressed by Mn(Fig. 
3A-B), demonstrating that Mn downregulates p73 in an isoform-specific manner. 
 
3.3 Downregulation of ∆Np73is not dependent on manganese-induced caspase-3 
activation 
Previous evidence indicates that manganese-induced neurotoxicity involves activation 
of caspase-3 signaling (Anantharam et al., 2004, Latchoumycandane et al., 2005). Moreover, 
caspase-3 has been shown to cleave p73 (Sayan et al., 2008).To investigate the possibility 
that activated caspase-3 contributes to the reduction of ∆Np73 protein levels by inducing 
proteolytic cleavage of ∆Np73, we used the cell-permeable, irreversible caspase-3 inhibitor 
zDEVD-fmk to selectively inhibit caspase-3 activation (Anantharam et al., 2004). Pre-
treatment of naïve N27 cells with zDEVD-fmk did not alter the expression level of ΔNp73. 
N27 dopaminergic cells were pre-exposed to either 20 or 50μM of zDEVD-fmk for 1 h 
46 
 
before exposure to 300μM of Mn. Interestingly, the Mn-induced downregulation of ∆Np73 
was unaffected by the presence of zDEVD-fmk (Fig. 4A-B), indicating that caspase-
dependent proteolytic cleavage is unlikely to be involved in the suppression of ∆Np73.  
 
3.4 Downregulation of ∆Np73 signaling sensitizes neurons to manganese-induced 
neurotoxicity 
Mn exposure induces mitochondria-mediated apoptosis in neurons, which is partially 
facilitated by p53 (Wan et al., 2014),and ∆Np73 antagonizes the functional p53 by regulating 
the expression of anti-apoptotic molecules such as Bcl-xL and MCl-1 (Basu and Haldar, 
1998, Grob et al., 2001, Melino et al., 2002, Huttinger-Kirchhof et al., 2006, Killick et al., 
2011, Conforti et al., 2012). We therefore investigated whether downregulation of ∆Np73 
affects Mn-induced dopaminergic neuronal cell death by altering the expression of key anti-
apoptotic proteins, such as Bcl-xL and Mcl-1. Interestingly, we found that expression of the 
anti-apoptotic proteins Bcl-xL (Fig. 5A-B) and Mcl-1 (Fig. 5C-D) was remarkably reduced 
by ~40-50% in N27 cells treated with 300 μM Mn. These results indicate that reduced 
∆Np73 levels may play an important role in Mn neurotoxicity. To further investigate the 
functional relevance of ∆Np73 downregulation, we overexpressed ∆Np73 in N27 cells and 
then exposed the cells to increasing concentrations of Mn for 24 h. ΔNp73 was 
overexpressed more than two-fold compared to vector control (Fig. 6A-B). Quantification of 
cell viability using MTS assay revealed that overexpression of ∆Np73 modestly inhibited the 
Mn-induced loss of cell viability during exposure to 100 and 200 μM Mn but unable to 
overcome the toxic effect of 300 μM Mn (Fig. 6C). Taken together, these data suggest that 
47 
 
∆Np73 suppression sensitizes dopaminergic cells to Mn-induced cell death and that the 
suppression of the anti-apoptotic ΔNp73 protein may contribute to Mn-induced neurotoxicity.  
 
4. Discussion 
In the present study, we provide evidence that the tumor suppressor gene p73 is 
highly susceptible to Mn-induced neurotoxicity in the nigrostriatal system. To our 
knowledge, this is the first evidence that Mn exerts its neurotoxic effects by suppressing 
expression of the anti-apoptotic ∆Np73 protein, thereby providing novel mechanistic insights 
into the molecular events underlying Mn neurotoxicity.  
Although several molecules have been identified as key mediators of Mn 
neurotoxicity leading to apoptosis, including the pro-apoptotic kinase PKCδ 
(Latchoumycandane et al., 2005, Zhang et al., 2007b), caspase-12, caspase-3 (Chun et al., 
2001, Wang et al., 2015), and p53 (Yang et al., 2007, Ma et al., 2015), the exact molecular 
and cellular mechanisms of how chronic Mn exposure induces dopaminergic neuronal cell 
death have not been fully characterized. The p73 protein has been shown to participate in a 
wide variety of cellular events, including cell death, self-renewal and cell cycle regulation 
(Killick et al., 2011, Di et al., 2013, Fatt et al., 2014, Engelmann et al., 2015). The p73protein 
has several isoforms characterized by alternative transcription at the N-terminus and 
alternative splicing at the C-terminus. Interestingly, TAp73isoforms having the N-terminal 
transactivation domain induce apoptosis, whereas ∆Np73isoforms lacking the transactivation 
domainantly agonize TAp73 functions, thereby favoring cell survival. We examined p73 
protein expression in an in vivo animal model exposed to 30 mg/kg for 30 days. Mn exposure 
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reduced total distance of movement compared to controls, showing Mn exposure induced SN 
degeneration (Fig. 1A-B). We also report that downregulation of the truncated p73 isoform, 
∆Np73, may play an important role in regulating neuronal cell survival during Mn exposure 
(Fig. 1C-D). 
Characterizing the isoform function of p73 may provide a better understanding of how Mn 
overexposure induces dopaminergic neuronal cell death. Our quantitative RT-PCR results 
revealed that Mn exposure downregulates p73 gene expression in N27 dopaminergic 
neuronal cells (Fig. 2A). The dose of 300 µM Mn in N27 cells is lower than 0.5-1 mM Mn 
used to induce toxic effects on mouse hippocampal neurons or human neuroblastoma cells 
(Tamm et al., 2008, Yoon et al., 2011). The concentration of Mn can reach up to 350 µM in 
certain brain regions (Ingersoll et al., 1999). Adult mice exposed to 30 mg/kg for 8 weeks 
showed the symptoms of Mn-induced toxicological effects (Moreno et al., 2009). Thus Mn 
concentrations used in our study were within the relevant toxicological range. The 
downregulation induced by 300 μM Mn occurred over 12 h in N27 cells, indicating that 
∆Np73 downregulation occurred during early stages of the cell death process. Our results 
from primary striatal neuronal cells exposed to different doses of Mn revealed that Mn 
downregulated the expression of ∆Np73 in a dose-dependent manner. Caspase-3 was shown 
to cleave full-length TAp73 under apoptotic conditions, releasing a 45 kDa fragment (Sayan 
et al., 2008). Our inhibition of caspase-3 failed to recover ∆Np73 suppression. Moreover, we 
did not observe a ~40 kDa cleaved product of ΔNp73. These data indicate that ∆Np73 
suppression involves caspase-3-independent mechanisms. Interestingly, p73 undergoes 
proteasomal degradation (Bernassola et al., 2004, Asher et al., 2005, Jung et al., 2011), but 
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further research is needed to reveal whether p73 degradation plays a role in Mn-induced 
∆Np73 repression. 
In addition to caspase-mediated proteolysis and proteasomal degradation, 
transcriptional suppression of the p73 gene is another important mechanism to negatively 
alter p73 activity (Chen et al., 2001, Putzer et al., 2003). Runt-related transcription factor 2 
and the transcription factor repressor ZEB bind to p73 promoter and transcriptionally 
suppress p73 expression (Fontemaggi et al., 2001, Bui et al., 2009, Ozaki et al., 2014). 
Additionally, epigenetic mechanisms, such as DNA hypermethylation, have been suggested 
to account for ∆Np73 transcriptional repression (Lai et al., 2014). Mn exposure induces DNA 
damage via oxidative stress (Oikawa et al., 2006, Stephenson et al., 2013) and upregulates 
p53 (Wan et al., 2014). Furthermore, genotoxic stress has been shown to selectively degrade 
∆Np73 via the antizyme AZ1 (Dulloo et al., 2010). It is plausible that DNA damage induced 
by Mn exposure via oxidative stress may reduce ∆Np73 and antagonize TAp73 as well as 
p53. Altered mRNA stability, protein stability and protein degradation mechanisms may also 
contribute Mn-induced ΔNp73 downregulation. Future studies will focus on providing 
further evidence and mechanisms for Mn-induced epigenetic transcriptional repression of the 
p73 gene. 
Bax is one of the transcriptional targets of the p73 gene (Melino et al., 2004, 
Graupner et al., 2011). Consistent with a previous report (Gonzalez et al., 2008), our results 
indicate that Mn exposure upregulated Bax (data not shown). Bcl-xL and Mcl-1 were 
reported to suppress activation of Bax and Bak, respectively (Sedlak et al., 1995, Finucane et 
al., 1999). Downregulation of Bcl-xL and Mcl-1 during Mn exposure (Fig. 5) indicates that 
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downregulation of ∆Np73 may play a role in fine-tuning the activity of p73. When we 
overexpressed ∆Np73 in N27 dopaminergic neurons, we observed a 2-fold increase in 
∆Np73 expression compared to vector-expressing N27 cells. After 24 h-post transfection, 
∆Np73 overexpression modestly inhibited against Mn-induced loss of viable cells (Fig. 6C) 
at low doses of 100 and 200 μM Mn, but not against the 300 μM dose. Considering that 
chronic exposure to low doses of Mn leads to neurodegeneration in the long-term, the modest 
protective effects against low Mn doses offered by ΔNp73 overexpression may play an 
important role. Further findings from an animal model of Mn neurotoxicity also supports that 
∆Np73 expression was downregulated in Mn-treated mice relative to controls, providing in 
vivo evidence that ∆Np73 plays an important role in Mn-induced neurotoxicity. Since Mn 
exposure downregulates ∆Np73 in an isoform-specific manner, this gene may have a 
potential value in the development of a biomarker for Mn exposure.    
In conclusion, our results demonstrate that ∆Np73downregulation significantly 
contributed to Mn neurotoxicity. These observations provide new insights into the 
mechanisms underlying Mn-induced dopaminergic neurotoxicity. Further characterization of 
the molecular mechanisms underlying ∆Np73downregulation will provide a better 
understanding of Mn-induced neurotoxicity.  
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Fig 1: Oral Mn administration downregulates ∆Np73 expression in the C57BL mouse 
model. Male C57BL mice were orally administered 30 mg/kg of Mn for 30 days, and vehicle 
control animals were administered de-ionized water. After treatments, locomotor activity was 
measured using an automated VersaMax locomotor activity monitor. Representative activity 
maps of open-field movements of Mn-treated mice and control mice revealed Mn-induced 
locomotor deficits (A). Mn treatment also reduced total distance traveled (cm) during a 10 
min test of locomotor activity(B). Western blot assays were performed on substantia nigral 
lysates to measure the expression of ∆Np73 (C). Densitometric analysis was also performed 
(D). Data are expressed as percent of control and represented as mean ± S.E.M. from four 
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animals per group. Asterisk (n=6-9, *, p < 0.05) indicates significant differences between 
treatment and control groups. 
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Fig 2: Mn exposure represses ∆Np73 gene and protein expression in N27 dopaminergic 
cells. N27 dopaminergic cells were exposed to 300 μM of Mn for 24 h in reduced sera. p73 
mRNA expression was examined by qRT-PCR (A). N27 cells were exposed to 300 µM of 
Mn in a time course over 24 h. Expression of ∆Np73 protein was measured by Western blot 
assays (B). Densitometric analysis was performed (C). Data are expressed as percent of 
control and represented as mean ± S.E.M. from three independent experiments. Asterisks 
(n=6-9, ***, p < 0.001; *,p<0.05) indicate significant differences between treatment and 
control groups. 
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Fig 3: Mn downregulates ∆Np73 in primary striatal neurons. Primary striatal neurons 
were exposed to 100-500μM of Mn for 24h in reduced sera. Expression of ∆Np73 protein 
was measured by Western blot assays (A). Densitometric analysis was performed (B). Data 
are expressed as percent of control and represented as mean ± S.E.M. from three independent 
experiments. Asterisks (n=6-9, *, p<0.05; **, p<0.01) indicate significant differences 
between treatment and control groups. 
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Fig 4: Caspase-3 inhibition does not alter the downregulation of ∆Np73during Mn-
induced neurotoxicity. N27 dopaminergic cells were pre-treated with either 20 or 50µM of 
the caspase-3 inhibitor zDEVD-fmk before exposure to 300 μM of Mn for 24 h in reduced 
sera. Expression of ∆Np73 protein was measured by Western blot assays (A). Densitometric 
analysis was performed (B). Data are expressed as percent of control and represented as 
mean ± S.E.M. from three independent experiments. Asterisks (n=6-9, *, p < 0.05; **, 
p<0.01) indicate significant differences between treatment and control groups. 
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Fig 5: Expression of the downstream effectors of the p73signaling pathway is also 
downregulated in Mn-induced neurotoxicity. N27 dopaminergic cells were exposed to 
100-500μM of Mn for 24h in reduced sera. Expression of Bcl-xL (A) and the longer isoform 
of MCl-1 (C) was measured by Western blot assays. Densitometric analysis was performed 
(B and D). Data are expressed as percent of control and represented as mean ± S.E.M. from 
three independent experiments for Bcl-xL and four independent experiments for Mcl-1, 
respectively. Asterisks (n=6-9, *, p < 0.05; ***,p<0.001) indicate significant differences 
between treatment and control groups. 
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Fig 6: Overexpression of ∆Np73 protects against Mn-induced neurotoxicity. N27 
dopaminergic cells were overexpressed with empty vector or ∆Np73. Cells were exposed to 
100-300μM of Mn for 24h in reduced sera. Expression of ∆Np73 protein was measured by 
Western blot assays (A). Densitometric analysis was performed (B). Cell survival was 
measured by MTS assay (C). Data are expressed as percent of control and represented as 
mean ± S.E.M. from six independent experiments for MTS assay. Asterisks (n=6-9, ***, 
p<0.001) indicate significant differences between ∆Np73-expressing and empty vector-
expressing groups. 
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Abstract 
Manganese (Mn) is an essential element found in most tissues. However, chronic exposure to 
Mn has been linked to the pathogenesis of manganism, which displays neurological 
abnormalities somewhat similar to those associated with Parkinson's disease. Yet, the cellular 
and molecular mechanisms underlying Mn-induced neurotoxicity have not been defined. 
Recently, we showed that protein kinase C delta (PKCδ) is one of the key mediators of Mn-
induced apoptosis in neuronal cells. To further characterize kinase-dependent cell death 
signaling mechanisms, we examined the effect of Mn on several signaling pathways, 
including signal transducer and activator of transcription (STAT). Interestingly, a 300  M 
Mn exposure in N27 dopaminergic neuronal cells over 12 h downregulated STAT5B protein 
levels in a time-dependent manner. However, STAT1 was unaffected during the Mn 
treatment, indicating an isoform-specific effect of Mn on STAT5B.  Quantitative RT-PCR 
analysis also showed that Mn treatment reduced STAT5B mRNA levels. Exposing primary 
striatal cultures to Mn also reduced STAT5B.  Furthermore, Bcl2, one of the downstream 
targets of STAT5B, was concomitantly reduced with STAT5B downregulation. Pretreatment 
of 20 μM Lactacystin failed to protect downregulation of STAT5B indicating STAT5B 
downregulation was independent of proteasomal degradation pathway. Pre-treatment of N-
Acetyl Cystine (NAC) was shown to protect downregulation of STAT5B. In addition, 
treatment of MPP+ in N27 cells showed downregulation of STAT5B. These results support 
the hypothesis that Mn exposure mediates oxidative stress that induces downregulation of 
STAT5B. Overexpression of STAT5B cells protected N27 cells against Mn-induced 
neurotoxicity. Furthermore, overexpression of STAT5B protected mitochondria in N27 cells. 
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Downregulation of STAT5B was recapitulated in substantia nigra of C57 black mice model 
treated with Mn and MitoPark Parkinson’s disease model. Furthermore, we show that Mn 
exposure suppresses promoter activity of STAT5B in MN9D dopaminergic cells. Finally, 
human lymphocytes show downregulation of STAT5B during Mn exposure, proposing a 
potential drug candidate for Mn-induced neurotoxicity and Parkinson’s disease patients. 
Taken together, our results suggest that Mn exposure downregulates STAT5B in striatal 
neurons and that Mn-induced downregulation of STAT5B may compromise the protective 
signaling pathway, thereby exacerbating neuronal cell death (NIH grants ES10586, ES19267, 
NS74443). 
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1. Introduction 
Neurodegenerative diseases have recently become more prevalent possibly due to 
aging, genetic alterations, and exposure to environmental toxicants such as pesticides, heavy 
metals and industrial byproducts. Manganese (Mn) has been used widely for more than two 
centuries in industry for various purposes. The main sources of Mn intake are through the 
daily diet and occupational exposure to Mn-containing fumes. Airborne Mn particles from 
various chemicals, including methylcyclopentadienyl manganese tricarbonyl (MMT) and 
fungicide, are another important source of public exposure (Bowman et al., 2011, Caudle et 
al., 2012, Michalke and Fernsebner, 2014). Mn is an essential trace element important in 
bone formation, fat and carbohydrate metabolism, blood sugar regulation, and calcium 
absorption. Mn serves as a co-factor for a variety of enzymes including superoxide dismutase 
2 and glutamine synthetase. However, overexposure to Mn causes a neurodegenerative 
disorder known as manganism, which is somewhat similar to Parkinson's disease (PD). Many 
of the pathological symptoms of manganism are also seen in PD patients including gait 
dysfunction, postural instability, bradykinesia, rigidity, and mask-like face expression. 
Manganism differs from PD in its lack of response to L-dopa therapy and in its early-phase 
neuropsychological sequelae. Both manganism and PD exhibit dopaminergic neuronal cell 
death in the substantia nigra (SN) and striatum (STR). 
Protein kinase C  (PKC ) is a n o vel redo x-sensitive PKC family kinase 
(Kanthasamy et al., 2003, Kaul et al., 2003). PKC  has been reported as a key mediator of 
the apoptotic process of various cells. PKC  is activated under oxidative stress conditions 
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such as environmental toxicant exposure. For example, when neuronal cells are exposed to 
excessive Mn, PKC  gets cleaved by Caspase-3, and the catalytic domain of PKC  gets 
released from the regulatory domain and phosphorylated. The resulting active form of 
PKC  translocates into the nucleus and activates its target proteins to orchestrate a series of 
processes preceding cellular apoptotic events. 
Signal transduction and activated transducer (STAT) is a transcription factor that 
transduces many extracellular biological signals to the nucleus to regulate specific genes. 
STAT has seven family members that share high structural homology. Activation of STATs 
begins with ligands binding to their cell membrane receptors, leading to activation of Janus-
kinase (JAK) by phosphorylation. Activated JAK allows the hetero- or homo-dimerization of 
proximal STATs before activation by phosphorylation. The phosphorylated STATs 
translocate to the nucleus where the extracellular signaling exerts fine and specific gene 
regulation (Paukku and Silvennoinen, 2004, Tan and Nevalainen, 2008). 
STAT5 was initially recognized as a mouse mammary gland factor before being 
renamed as STAT5 because of its significant sequence homology with other STAT members. 
STAT5 has two isoforms, STAT5A and STAT5B, which have a high 90%sequence 
homology, with their main difference being a sequence in the C-terminal where the 
transcription activation domain is located. Though STAT5A and STAT5B share their target 
genes, they have distinctive roles. They have non-redundant target genes, different profiles of 
interactions with other co-factors, and different cell type-specific expression profiles (Tan 
and Nevalainen, 2008, Kanai et al., 2014). STAT5B mediates cellular growth and 
proliferation, while STAT5A mediates the development and differentiation of mammary 
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glands. STAT5B-/- mice show impaired growth due to the loss of growth hormone (GH) 
responsiveness while STAT5A-/- mice show impaired mammary gland development due to 
the loss of prolactin (Prl) signaling (Buitenhuis et al., 2004, Paukku and Silvennoinen, 2004). 
Knocked-down expression of STAT5B has also been shown to compromise cellular 
protection against reactive oxygen species (ROS) in peripheral neuronal system(Du et al.). 
With much attention focused on Mn-induced neurotoxicity, the question of how 
dopaminergic neuronal cell death happens at the molecular-cellular levels recently began to 
be solved. Hilary et al. showed that Mn nanoparticles cause dopaminergic neuronal cell death 
through mitochondrial-dependent apoptotic signaling and autophagy (Afeseh Ngwa et al., 
2011). Our group has recently shown that PKC  is an important key mediator in driving 
dopaminergic neuronal cell death (Kanthasamy et al., 2003, Kaul et al., 2003, Jin et al., 
2011a). However, despite extensive research, we still need to delineate more clearly the 
mechanisms connecting Mn neurotoxicity and Parkinsonian disorders. In this report, we 
investigate whether regulation of STAT5B expression may be involved in Mn-induced 
dopaminergic neuronal cell death. 
 
2. Materials and Methods 
2.1 Chemicals 
Manganese chloride (MnCl2, 99%), MPP+, and MPTP were purchased from Sigma-Aldrich 
(St. Louis, MO). Antibodies against Bcl-2 and STAT5B were purchased from Santa Cruz 
Biotechnology (Santa Cruz, CA). Antibodies against phospho-STAT5and STAT1 were purchased 
from Cell signaling (Danvers, MA). Bradford protein assay kit was purchased from Bio-Rad 
Laboratories (Hercules, CA). Antibody against β-Actin was purchased from Sigma-Aldrich. The anti-
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mouse and anti-rabbit secondary antibodies (Alexa Fluor 680 conjugated anti-mouse IgG and IRdye 
800 conjugated anti-rabbit IgG) were purchased from Life Technologies (Grand Island, NY) and 
Rockland (Gilbertsville, PA), respectively. RPMI1640, fetal bovine serum (FBS), L-glutamine, 
penicillin, and streptomycin were purchased from Life Technologies. MitoTracker Red was 
purchased from Life Technologies. N-acetyl-L-cysteine was purchased from Sigma-Aldrich (St. 
Louise, MO). Lactacystin was purchased from Cayman chemical (Ann Arbor, MI). CellTiter® 96 
AQueous Assay and Nano-Glo® Luciferase assay system were purchased from Promega (Madison, 
WI).  
2.2 Animal studies 
Six- to eight-week-old male C57BL/6J mice were purchased from Charles River (Chicago, 
IL). MitoPark mice were kindly gifted from Dr. Nils-Goran Larson at the Max Planck Institute for 
Biology and Ageing in Cologne, Germany. MitoPark mice were maintained, bred and genotyped at 
Iowa State University (ISU). Animals were housed at RT under a 12-h light cycle with water and 
food provided ad libitum. Mn (30mg/kg) was orally administered daily for 30 days. MPTP (30mg/kg) 
was administered intraperitoneally for 4 days. Animals were cared for according to protocols 
approved by the Institutional Animal Care and Use Committee at ISU. After the treatment period, the 
striatum was dissected for measuring the expression of proteins of interest.  
2.3 Cell cultures and treatment 
A rat-derived dopaminergic neuronal cell line, N27, was kindly gifted from Dr. Kedar N. 
Prasad at the University of Colorado Health Sciences Center, Denver, CO (Adams et al., 1996). N27 
cells and MN9D cells, a mouse-derived dopaminergic neuronal cell line, were maintained in RPMI 
1640 media supplemented with 10% FBS, 2mM L-glutamine, 50 units of penicillin, and 50µg/ml of 
streptomycin in a humidified incubator with 5% CO2 at 37°C as described previously(Jin et al., 
2011b, Latchoumycandane et al., 2011). After exposing N27 cells to various concentrations of Mn 
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(100-500 μM) for 24 h, the cells were subjected to quantitative real-time PCR (qRT-PCR) or 
immunocytochemical analysis. Human lymphocytes from Parkinson's disease patients and population 
control subjects were purchased from the Corriell Institute for Medical Research (Camden, NJ). 
Lymphocytes were maintained in RPMI 1640 media supplemented with 15% raw FBS, 2mM L-
glutamine, 50units of penicillin, and 50μg/ml of streptomycin in a humidified incubator with 5% CO2 
at 37°C. 
2.4 Primary striatal cultures and treatment 
The primary striatal neuronal cultures were prepared as described previously from the 
ganglionic eminences of gestational 14- to 15-day-old mouse embryos(Jin et al., 2014a). Briefly, after 
removing the embryonic brain, the embryonic cerebral cortex was folded away to expose ganglionic 
eminences and striatum for dissection, which were then washed in Dulbecco's modified Eagle’s 
media (DMEM) and dissociated with trypsinization. Dissociated cells were seeded into poly-D-lysine 
(PDL)-coated plates and maintained in neurobasal medium supplemented with B-27 supplements, 
500mM L-glutamine, 100 IU/ml penicillin, and 100ug/ml streptomycin in a humidified incubator 
with 5% CO2 at 37°C. Four- to six-day-cultured primary striatal neuronal cells were exposed to Mn 
under various conditions. 
2.5 Plasmid constructs 
STAT5B expression vector was kindly gifted from Dr. Lobie, Department of Molecular 
Medicine and Pathology, University of Auckland, New Zealand. For the promoter reporter system, 
the forward primer (5'- TACTAGTCCTCGAGAGCTTCTTGGCCCAGCCCCCACGCTCTC-3') and 
reverse primer (5'- TACTAGTCAAGCTTGCCACCACCAGCGCCCCGGGCCCCTC-3') were used 
to amplify mouse STAT5B promoter regions from mouse genomic DNA. The resulting PCR 
amplicon was digested with restriction enzyme before ligation to pNL1.1 NLuc vector (Promega).  
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2.6 Promoter activity assay 
MN9D cells were transfected with luciferase vector fused with either STAT5B promoter or 
empty vector together with lacZ vector using Lipofectamine2000 (Life Sciences) 24 h prior to 
exposure to Mn. Treated cells were collected and lysed with lysis buffer (Promega) for the 
measurement of luciferase activity using Nano-glo® Luciferase assay system (Promega). Cell lysates 
were further analyzed for β-galactosidase activity, which was used for normalization. 
2.7 Transfections 
N27 cells were transfected with 10ug of pcDNA3 vector or pcDNA3-expressing STAT5B 
through electroporation. The Amaxa Nucleofector instrument was used according to manufacturer's 
protocol. Transfected cells were seeded in either T-75 flasks or 96-well plates as desired for 24 h 
before treatment.  
2.8 Cell proliferation assays 
Cell survival was measured by colorimetric MTS assay (CellTiter® 96 AQueous Assay). 
Cells were seeded in 96-well plates before exposure to Mn. At the end of treatment, 20% MTS 
reagent was added to each well. The MTS tetrazolium compound is bio-reduced in living cells to its 
colored formazan products. After incubating for up to an hour, absorbance at 490nm was measured 
using a SpectraMax spectrophotometric plate reader (Molecular Devices). 
2.9 Quantitative real-time RT-PCR 
After treatment, total RNA was extracted from cells or tissues using an Absolutely RNA Mini 
Extraction Kit (Agilent Technologies, Santa Clara, CA) according to manufacturer's protocol. Total 
RNA was treated with DNase I during extraction of total RNA and converted to cDNA using the 
High Capacity cDNA Synthesis Kit (Life Technology, Grand Island, NY).SYBR Green quantitative 
PCR was performed. Forward primer (5'-GCAATGATTATAGCGGCGAGA-3') and reverse primer (5'-
CAAAGGCGTTGTCCCAGAGG-3') were used for detection of STAT5B mRNA. Primers for 18S RNA 
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(Qiagen) were used as the housekeeping gene (control). The threshold cycle (Ct) was calculated from 
the instrument software, and fold change of gene expression for pair-wise comparisons was calculated 
using the∆∆Ct method. 
2.10 Western blotting 
Cells were lysed in lysis buffer (1% Triton X-100, 1mM EDTA, 100mM NaCl, 1mM EGTA, 
1mM NaF, 20mM Na4P2O7, 2mM Na3VO4, 10% glycerol, 0.1% SDS, 0.5% deoxycholate, 50mM 
Tris-Cl, pH7.4). Brain homogenates were prepared as described previously (Ghosh et al., 
2013).Western blotting was performed as described previously (Jin et al., 2014b). Briefly, the 
samples containing equal amounts of proteins were fractionated through a 10 to 15% SDS-PAGE gel 
and transferred onto a nitrocellulose membrane. Primary antibodies against specific proteins were 
incubated with the membrane. After thoroughly rinsing in PBS supplemented with 0.1% Tween-20, 
the membrane was incubated with either Alexa Fluor 680 goat anti-mouse, Alexa Fluor 680 donkey 
anti-goat (Invitrogen, Carlsbad, CA, USA), or IRDye 800 donkey anti-rabbit secondary antibodies 
(Rockland, Gilbertsville, PA, USA). For loading control, β-Actin was used. Immunoblot imaging was 
performed with an Odyssey Infrared Imaging system (LI-COR, Lincoln, NE, USA). ImageJ software 
(National Institutes of Health, Bethesda, MD, USA) was used to quantify Western blot bands.  
2.11 Mitochondrial dysfunction assay 
 The mitochondrial dysfunction assay has been previously described (Charli et al., 2015). 
Briefly, cells were grown on PDL-coated glass slides and exposed to Mn. Cells were washed with 
PBS and stained with 200nM MitoTracker Red dye diluted in serum-free RPMI media before fixation 
in 4% paraformaldehyde (PFA) for 30min. Cell images were taken at 60x magnification and captured 
with a SPOT color digital camera. 
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2.12 Immunostaining and Microscopy 
N27 cells were grown on PDL-coated glass slides and exposed to Mn. The treated N27 cells 
were fixed and blocked by incubating in 4% PFA for 30min and in blocking buffer (2% bovine serum 
albumin, 0.5% Triton X-100, 0.05% Tween-20 in PBS), respectively. Cells were incubated overnight 
at 4°Cwith antibody against STAT5B (1:500, Santa Cruz Biotechnology). After washing, cells were 
incubated with fluorescently conjugated secondary antibody (Alexa Fluor 555-conjugated anti-mouse 
antibody, 1:2000) to visualize protein. Hoechst 33342 (10µg/mL) was used for nuclear staining. 
Images were taken at 60× magnification with a SPOT color digital camera attached to a Nikon 
TE2000 microscope and processed using ImageJ software. 
2.13 Statistical analysis 
Data were analyzed using Prism 4.0 software (GraphPad Software, San Diego, CA). Paired 
Student t-tests were performed. Tukey's multiple comparison test was used after ANOVA for 
comparing differences between multiple groups. Differences were considered statistically significant 
if p-values < 0.05 were obtained. Data are represented as the mean ± S.E.M. of at least two separate 
experiments performed at least in triplicate. 
 
3. Results 
3.1 Downregulation of STAT5B in dopaminergic neurons after Mn-induced 
neurotoxicity 
Mn neurotoxicity induces activation of protein kinase C  (PKC ), a no vel redox-
sensitive PKC family kinase (Kanthasamy et al., 2003, Kaul et al., 2003). PKC  has also 
been reported as a key mediator in the apoptotic process of various cells, making it important 
to identify its downstream targets during Mn-induced neurotoxicity, for which STAT family 
members might be one. Unexpectedly, exposing dopaminergic neuronal cells to 300 µM of 
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Mn downregulated STAT5B expression by over 70% (Fig. 1 A and B). STAT1 expression 
was not significantly altered compared to control, indicating isoform-specific regulation of 
STATs during Mn exposure. Expression of STAT5B at the transcriptional level was 
investigated by performing qRT-PCR. Surprisingly, Mn exposure downregulated STAT5B 
transcription by more than 80% compared to control (Fig. 1 C). The activated phosphorylated 
form of STAT5B was also significantly downregulated by more than 50% compared to 
control. To characterize the subcellular localization of STAT5B during Mn exposure, 
immunocytochemistry analysis was performed. The amount of STAT5B in the nucleus of 
Mn-treated N27 cells was significantly lower than in control cells (Fig. 1D). 
 
3.2 Profiles of STAT5B downregulation 
   We measured the expression of STAT5B at various time points during Mn 
exposure. N27 cells were exposed to 300 µM of Mn for 3, 6, 9 and 12 h. Downregulation of 
STAT5B began as early as 3 h after Mn exposure (Fig. 2A). Mn-induced cytotoxicity 
downregulated STAT5B expression in a time-dependent manner, with peak suppression of 
STAT5B occurring at 12 h. To preclude the possibility that the Mn-induced STAT5B 
downregulation was specific to the N27 cell model, the experiment was repeated in another 
commonly used dopaminergic neuronal cell line, MN9D cells. As with N27 cells, Mn 
exposure to 300 µM for 12 h resulted in significant downregulation of STAT5B in the 
MN9D cell culture model (data not shown). The evaluation of expression of STAT5B during 
Mn exposure was further extended to mouse primary striatal cultures. 
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Next, we tested the effects of Mn cytotoxicity on mouse primary striatal cultures by 
exposing them to 0, 100, 200, 300, and 500 µM of Mn for 24 h (Fig. 2C). Again, we 
observed a dose- and time-dependent downregulation of STAT5B. Exposure to 100 µM Mn 
significantly downregulated STAT5B expression by more than30%, while 300 µM Mn 
suppressed expression by roughly 50% (Fig. 2D). Phosphorylated STAT5B can be degraded 
through the proteasomal degradation pathway, and we used lactacystin to investigate the 
effects of Mn on the STAT5B proteasomal degradation pathway (Fig. 3C). N27 cells were 
pre-treated with 20 µM lactacystin 1 h before being exposed to 300 µM Mn. Pretreatment 
with lactacystin alone did not induce any phenotypic damage to the neuronal cells. 
Unexpectedly, lactacystin failed to prevent STAT5B downregulation during Mn exposure, 
indicating the possibility that other systems, including transcriptional regulation, may be 
involved in suppressing STAT5B expression. Future studies will explore the mechanisms of 
how Mn exposure induces STAT5B downregulation. 
 
3.3 Effects of downregulation of STAT5B on dopaminergic neurons 
Activated STATs induce the expression of their target genes depending on signals, 
tissue type, and time. We examined the expression of several target genes to unravel the 
cascade of signaling molecules following Mn exposure in dopaminergic neurons. Bcl-2 was 
downregulated concomitantly with STAT5B by more than 50% relative to controls 12 h after 
exposure to 300 µM Mn (Fig. 3A). The dose- and time-dependent downregulation of Bcl-2 
began 6 h post-exposure (data not shown). Bcl-2 is known to be anti-apoptotic. Therefore its 
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downregulation might suppress cellular protective mechanisms against Mn-induced 
cytotoxicity.  
 
3.4 Suppression of oxidative stress protects STAT5B during Mn exposure 
Mn overexposure induces oxidative stress (Erikson et al., 2004). To investigate 
whether Mn-induced oxidative stress plays a role in STAT5B downregulation, we pre-treated 
N27 cells with 1mM of the anti-oxidant agent N-acetyl cysteine (NAC) just 1 h before 
exposure to 300 µM Mn (Fig. 4). The NAC pretreatment induced higher STAT5B expression 
compared to Mn alone, while NAC alone did not have any effect. To investigate whether 
excessive oxidative stress can also induce STAT5B downregulation, we treated N27 
dopaminergic neuronal cells with 300 μM of the widely known toxicant MPP+, which causes 
PD-like symptoms and induces oxidative stress. Treatment with MPP+ significantly 
downregulated STAT5B by more than 40% compared to the control group. These results 
indicate that Mn-induced neurotoxicity may require oxidative stress to induce 
downregulation of STAT5B expression. 
 
3.5 Overexpression of STAT5B protect neuronal cells in Mn-induced cytotoxicity 
We overexpressed the STAT5B protein in dopaminergic neurons before exposing 
them for 48 h to various amounts of Mn in 2% FBS. Then cell survival was measured using 
the MTS-based cell proliferation assay, in which metabolically active cells reduce MTS to 
purple-colored formazan (Fig. 5A). Overexpression of STAT5B significantly protected 
neuronal cells from exposure to 100 and 200    Mn, but not 300    Mn. These results 
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suggest that sustained STAT5B expression offers cellular protection against Mn-induced 
neurotoxicity so long as the Mn insult is not too strong. Overexpression of STAT5B also 
sustained Bcl-2 expression during Mn-exposure, indicating that the protective mechanism 
may be mediated through Bcl-2-related cell signaling (Fig. 5B). 
 
3.6 Overexpression of STAT5B protects mitochondria in neuronal cells during Mn 
exposure 
One STAT5B function is to regulate energy metabolism and to be involved in 
mitochondrial regulation (Du et al., 2012). Since the anti-oxidant reagent NAC protected 
STAT5B from Mn-induced neurotoxicity, we explored the possibility that STAT5B affects 
mitochondrial biogenesis. N27 dopaminergic neuronal cells overexpressing STAT5B-GFP 
were stained with MitoTracker red dye after exposure to Mn. Mitochondrial structure was 
analyzed and quantified with ImageJ software. Mitochondria in control groups showed long 
thread-like mitochondria distributed randomly in the cytosol. In contrast, mitochondria in 
GFP-expressing neuronal cells were significantly damaged after Mn exposure, exhibiting a 
disintegrated and disconnected circular form indicative of mitochondrial fission. Thus, Mn 
exposure induced mitochondrial damage in dopaminergic neuronal cells overexpressing GFP, 
however, overexpression of STAT5B-GFP significantly protected mitochondria from Mn-
induced neurotoxicity (Fig 6A), allowing the dopaminergic neuronal cells to retain longer 
thread like mitochondria (Fig 6B).Circularity of mitochondria in STAT5B-GFP-
overexpressing cells was lower than in GFP-expressing cells. These results showed that 
STAT5B plays a role in protecting mitochondria during Mn exposure. 
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3.7 Downregulation of STAT5B in vivo 
To investigate whether Mn exposure suppresses STAT5B in vivo, C57 black mice 
were administered 30mg/kg of Mn via oral gavage for 30 days before performing behavioral 
and biochemical analyses (Fig. 7). The Mn-treated group traveled a shorter distance than did 
the control group, indicating that Mn exposure affected the SN, which governs body 
movement (data not shown). The SN was dissected for further biochemical analyses. 
Expression of STAT5B was measured by Western blot and normalized to β-Actin. 
Densitometric analysis showed Mn exposure induced more than a 50% downregulation of 
STAT5B in the SN when compared to the control group. 
C57 black mice were treated with 30mg/kg MPTP for 4 days and sacrificed on the 5th 
day to investigate whether MPTP exposure alters STAT5B expression. Interestingly, MPTP 
exposure induced more than a 60% downregulation of STAT5B (Fig 8). As STAT5B 
downregulation was surprisingly responsive to toxicants such as Mn and MPTP, we tested 
STAT5B expression in yet another PD model known as MitoPark, a progressive genetic 
mouse model of PD. We compared the STAT5B expression levels of 25-wk-old MitoPark 
mice to C57 black mice serving as age-matched controls. Densitometric analysis of the 
Western blot of striatal tissue lysates showed more than a 50% reduction of STAT5B 
expression in MitoPark mice (Fig. 9). We further analyzed STAT5B expression in different 
age groups. MitoPark mice begin to exhibit reduced STAT5B in the SN at 12 wk and 
STAT5B expression continues to progressively degenerate as they age (data not 
shown).These results show that STAT5B expression was responsive to toxicants, which 
induced its downregulation in vivo. 
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3. 8 Promoter 1 activity of mouse STAT5B was repressed during Mn exposure 
The finding that the mRNA level of STAT5B was downregulated during Mn 
exposure prompted us to investigate its promoter activity during Mn exposure in mice. We 
cloned the STAT5B promoter 1 region from 1000 bp upstream to 500 bp downstream and 
attached a Luciferase reporter gene. We transfected the resulting mini STAT5B promoter 
reporter gene into MN9D cells, which is another well-known mouse dopaminergic neuronal 
cell line. After a 9h exposure to 300μM Mn, promoter activity was suppressed by more than 
50%, which indicates that Mn-induced transcriptional regulation of STAT5B plays an 
important role in downregulating STAT5B expression. The response of promoter activity to 
Mn exposure remains to be characterized. 
 
3.9 STAT5B as potential biomarker for Mn exposure 
The high sensitivity of dopaminergic neurons to Mn prompted us to explore whether 
STAT5B could serve as a biomarker for PD-like symptoms including manganism. For this 
study, we compared human lymphocytes from both PD patients and a population control 
group. PD patients were 59-60 years old. Human lymphocytes were exposed for 24 h to 
various concentration of Mn ranging from 100μM to 500μM, and then we measured cell 
survival using the trypan blue assay in a Vi-CELL cell viability analyzer. The lower 
concentration of 100 μM Mn induced 50% cell death in reduced serum-complemented media 
(data not shown). STAT5B was downregulated in Mn-treated lymphocytes for both the 
population control and PD patient groups. These results show that STAT5B expression is 
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very sensitive to Mn exposure in lymphocytes and may serve as a biomarker for Mn-induced 
toxicity. 
 
4. Discussion 
Manganese’s versatile redox states ranging from Mn2+ to Mn7+ serve important roles 
in many biochemical reactions in most living organisms including mammals. However, 
overexposure to Mn promotes the development of neurodegenerative diseases similar to 
idiopathic PD. Yet it remains unclear how Mn exposure causes neuronal cell death. In the 
present study, we demonstrate that Mn exposure downregulates the native and 
phosphorylated forms of STAT5B at both the protein and mRNA levels (Fig. 1), while 
STAT1 expression remains stable. Thus, Mn exposure appears to selectively downregulate 
STAT5B, suggesting that STAT5B plays important roles in Mn-induced neurotoxicity. 
STAT5B becomes functional or activated when it is phosphorylated at Y699, as Y699-
phosphorylated STAT5B (pSTAT5B) is transported to the nucleus where it activates its 
downstream effector molecules. We determined that Mn exposure indeed reduced pSTAT5B 
in N27 dopaminergic neuronal cells. Immunocytochemistry (ICC) of the subcellular 
localization of STAT5B revealed that nuclear STAT5B was also downregulated in N27 
dopaminergic neuronal cells during Mn exposure. In addition to expression levels of the 
STAT5B protein, mRNA levels of STAT5B were also downregulated during Mn exposure, 
as quantitative RT-PCR results showed. 
STATs play important roles in transducing and activating extracellular signals 
(Paukku and Silvennoinen, 2004). Receptors activated by extracellular signals such as 
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hormones and cytokines in turn induce phosphorylation of STAT molecules which act as 
transcription activators. In most cases, cells regulate the action of STAT5B by modulating its 
phosphorylation status through many mechanisms including phosphatase and PIAS. 
Interestingly, our results show that Mn exposure induces the downregulation of both the 
native and phosphorylated forms of STAT5B, which is a novel way of modulating STAT5B 
functions. STAT5B downregulation occurred in a dose- and time-dependent manner, with a 
significant drop in protein levels beginning as early as 6h after Mn exposure. Similarly, ICC 
results also showed nuclear STAT5B to be downregulated within 6h. Wang et al. (Wang et 
al., 2000) showed that the protease inhibitor MG132 and the phosphatase inhibitor sodium 
orthovanadate (SO) each protected IL-3-dependent myeloid cells against the downregulation 
of pSTAT5a, though SO did so to a lesser degree. To confirm that the STAT5B 
downregulation was not specific to one neuronal cell line, we also examined the effects of 
Mn exposure on other neuronal cell cultures. The mouse dopaminergic neuronal MN9D cell 
line exhibited similar STAT5B downregulation during Mn exposure (data not shown). 
Furthermore, primary mesencephalic striatal cells were cultured from E14 embryonic pups 
and exposed to various concentration of Mn for 24h. Similar to N27 cells, mouse primary 
striatal cell cultures showed STAT5B downregulation in a dose-dependent manner (Fig. 2 C). 
STAT5A has been shown to be regulated by proteasomal proteolysis, although the 
investigators acknowledged that mishandling of samples may have contributed to the 
degradation process(Wang et al., 2000, Ramos et al., 2007). To determine whether STAT5B 
might be degraded via proteasome-dependent proteolysis, we used lactacystin to inhibit 
proteasomal protein degradation. Pre-treatment with lactacystin failed to protect against 
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STAT5B downregulation during Mn exposure, indicating that another system mediates the 
downregulation of STAT5B. 
It is possible that microRNA plays a role in regulating STAT5B expression, whose 
decrease in myometrial tissues during pregnancy has been shown to be mediated by miR-
200a (Williams et al., 2012). However, whether similar miRNA-mediated suppression of 
STAT5B occurs in other cell types like neurons still needs to be explored. Mouse STAT5B 
has two alternative promoters. Promoter 1 shares high homology with both the human and rat 
promoter, whereas promoter 2 is exclusive to the mouse. The human STAT5B promoter has 
SP1 binding sites and methylation-associated CpG binding sites (Crispi et al., 2004). It is 
possible that Mn exposure disrupts transcription factor activity to reduce transcription of 
STAT5B. When we examined downstream targets of STAT5B, Bcl-2 was concomitantly 
downregulated with STAT5B. Bcl-2 has been known to play an anti-apoptotic role and to 
initiate protective mechanisms. In this case, Mn exacerbates its cytotoxicity by turning down 
the anti-apoptotic STAT5B pathway. Characterization of its systemic mechanisms may 
reveal potential drug targets to alleviate or prevent Mn-induced neurodegeneration. 
One way Mn exerts its cytotoxicity is to generate reactive oxygen species (ROS). 
Hence, we examined whether ROS plays a role in STAT5B downregulation by pre-treating 
N27 cells with 1 mM NAC, an anti-oxidative stress agent, 1 h before a 300 μM Mn treatment 
lasting 9h. We chose a 9 h post-Mn time point to allow for NAC’s protective effect before 
major Mn-induced neurotoxicity was manifested. Surprisingly, NAC significantly protected 
STAT5B expression against Mn-induced neurotoxicity as the NAC treated groups showed 
roughly double the amount of STAT5B expression when compared to Mn alone. 
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Furthermore, we challenged N27 dopaminergic neuronal cells with MPP+, which is a widely 
known toxicant that produces ROS, thereby inducing oxidative stress leading to 
neurodegeneration. Treatment with 300 μM MPP+ for 12 h downregulated STAT5B by more 
than 40%, indicating that oxidative stress plays an important role in regulating STAT5B 
expression.  
To investigate specific roles of STAT5B in Mn-induced neurotoxicity, STAT5B was 
overexpressed in N27 dopaminergic neurons. Our cell viability assay showed that STAT5B 
contributes significantly to protecting neurons from Mn-induced neurotoxicity. Bcl-2, a 
target substrate of STAT5B, was also protected from Mn-induced suppression, showing 
higher expression levels under STAT5B overexpression, supporting our hypothesis that 
STAT5B is protective during Mn exposure.  Bcl-2 suppresses the release of cytochrome C, 
which plays a pivotal role in inducing mitochondria-mediated apoptosis. Thus, it is 
conceivable that overexpressing STAT5B elicits protective effects by retaining higher levels 
of Bcl-2. Furthermore, mitochondrial staining by MitoTracker revealed that STAT5B 
overexpression supported relatively healthier mitochondria compared to Mn-treated group 
(Fig. 6 A). Mitochondria are long and thread-like under normal conditions. However, Mn 
exposure resulted in mitochondria becoming disconnected and circular in shape. In contrast, 
STAT5B overexpression helped maintain longer mitochondria with a lower degree of 
circularity (Fig. 6B and C). Furthermore, STAT5B overexpression induced a higher 
mitochondrial DNA copy number of mitochondrial D loop regions (Fig 6D). Mitochondrial 
DNA replication is initiated at D loop regions, which are non-coding regions interact with 
cis- and trans- factors such as nuclear respiratory factors (NRF). Mitochondria react to 
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cellular stress such as oxidative stress by increasing mitochondrial DNA copy number and 
mass. For instance, rotenone treatment can induce a two-fold increase of mitochondrial DNA, 
while H2O2 treatment can upregulate nuclear and mitochondrial genes. Thus, overexpression 
of STAT5B revives mitochondrial protection mechanisms. 
Downregulation of STAT5B was further characterized in vivo. C57 black mice 
exposed orally to 30 mg/kg Mn for 30days showed significant downregulation of STAT5B in 
the SN (Fig. 7), where Mn accumulates more than in other brain regions. The degeneration of 
dopaminergic neurons is a major cause of motor behavioral dysregulation in both PD patients 
and Mn-exposed patients. In addition, 30 mg/kg MPTP also downregulated STAT5B in the 
SN. These in vivo results further support our hypothesis that Mn downregulates STAT5B 
protein and its functions to exert its cytotoxicity. In MitoPark mice, which have TFAM 
knocked out under the DAT promoter, striatal STAT5B expression was exhibited in 25-
week-old mice. Unlike other toxin-related PD models, MitoPark mice show gradual, 
progressive dopaminergic neuronal degeneration. Interestingly, MitoPark mice also showed 
progressive downregulation of STAT5B in the SN (data not shown). These results taken 
together demonstrate that Mn downregulates native and phosphorylated forms of STAT5B. 
We demonstrated that oxidative stress induces the downregulation of STAT5B 
expression in a Mn dose- and time-dependent manner. The in vitro findings were reaffirmed 
in several animal models. Then we asked if STAT5B can serve as a potential candidate for 
biomarkers for neurotoxicant-induced oxidative stress. The serum level of Mn does not 
reliably reflect actual Mn exposure since both the range of serum Mn levels varies and other 
tissues tend to absorb Mn for long durations (Zheng et al., 2011). However, changes in 
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STAT5B expression reflect Mn cytotoxicity. In addition, quantitative measurement of 
STAT5B at the mRNA level negates having to rely on complex procedures and tools such as 
size exclusion chromatography and inductively coupled plasma mass spectrometry. 
In conclusion, this report shows novel mechanisms of downregulation of signaling 
molecules that contribute to dopaminergic neuronal loss. Our work also provides a novel 
therapeutic target for Parkinsonian patients as many drugs for the STAT5 molecule have 
been developed. 
 
Conflict of interest 
The authors declare no conflicts of interest. 
 
Acknowledgments 
We thank the support from NIH grants ES10586, ES19267, NS74443. We also thank 
Gary Zenitsky for his assistance with manuscript preparation. 
92 
 
References 
Adams FS, La Rosa FG, Kumar S, Edwards-Prasad J, Kentroti S, Vernadakis A, Freed CR, 
Prasad KN (1996) Characterization and transplantation of two neuronal cell lines with 
dopaminergic properties. Neurochem Res 21:619-627. 
Afeseh Ngwa H, Kanthasamy A, Gu Y, Fang N, Anantharam V, Kanthasamy AG (2011) 
Manganese nanoparticle activates mitochondrial dependent apoptotic signaling and 
autophagy in dopaminergic neuronal cells. Toxicology and applied pharmacology 
256:227-240. 
Bowman AB, Kwakye GF, Herrero Hernandez E, Aschner M (2011) Role of manganese in 
neurodegenerative diseases. J Trace Elem Med Biol 25:191-203. 
Buitenhuis M, Coffer PJ, Koenderman L (2004) Signal transducer and activator of 
transcription 5 (STAT5). Int J Biochem Cell Biol 36:2120-2124. 
Caudle WM, Guillot TS, Lazo CR, Miller GW (2012) Industrial toxicants and Parkinson's 
disease. Neurotoxicology 33:178-188. 
Charli A, Jin H, Anantharam V, Kanthasamy A, Kanthasamy AG (2015) Alterations in 
mitochondrial dynamics induced by tebufenpyrad and pyridaben in a dopaminergic 
neuronal cell culture model. Neurotoxicology. 
Crispi S, Sanzari E, Monfregola J, De Felice N, Fimiani G, Ambrosio R, D'Urso M, Ursini 
MV (2004) Characterization of the human STAT5A and STAT5B promoters: 
evidence of a positive and negative mechanism of transcriptional regulation. FEBS 
Lett 562:27-34. 
93 
 
Du W, Wang YC, Hong J, Su WY, Lin YW, Lu R, Xiong H, Fang JY STAT5 isoforms 
regulate colorectal cancer cell apoptosis via reduction of mitochondrial membrane 
potential and generation of reactive oxygen species. J Cell Physiol. 
Du W, Wang YC, Hong J, Su WY, Lin YW, Lu R, Xiong H, Fang JY (2012) STAT5 
isoforms regulate colorectal cancer cell apoptosis via reduction of mitochondrial 
membrane potential and generation of reactive oxygen species. J Cell Physiol 
227:2421-2429. 
Erikson KM, Dobson AW, Dorman DC, Aschner M (2004) Manganese exposure and 
induced oxidative stress in the rat brain. The Science of the total environment 334-
335:409-416. 
Ghosh A, Saminathan H, Kanthasamy A, Anantharam V, Jin H, Sondarva G, Harischandra 
DS, Qian Z, Rana A, Kanthasamy AG (2013) The peptidyl-prolyl isomerase Pin1 up-
regulation and proapoptotic function in dopaminergic neurons: relevance to the 
pathogenesis of Parkinson disease. J Biol Chem 288:21955-21971. 
Jin H, Kanthasamy A, Anantharam V, Rana A, Kanthasamy AG (2011a) Transcriptional 
regulation of pro-apoptotic protein kinase Cdelta: implications for oxidative stress-
induced neuronal cell death. J Biol Chem 286:19840-19859. 
Jin H, Kanthasamy A, Ghosh A, Yang Y, Anantharam V, Kanthasamy AG (2011b) alpha-
Synuclein negatively regulates protein kinase Cdelta expression to suppress apoptosis 
in dopaminergic neurons by reducing p300 histone acetyltransferase activity. J 
Neurosci 31:2035-2051. 
94 
 
Jin H, Kanthasamy A, Harischandra DS, Kondru N, Ghosh A, Panicker N, Anantharam V, 
Rana A, Kanthasamy AG (2014a)  
J Biol Chem 289:34743-34767. 
Jin H, Kanthasamy A, Harischandra DS, Kondru N, Ghosh A, Panicker N, Anantharam V, 
Rana A, Kanthasamy AG (2014b) Histone Hyperacetylation Upregulates PKCdelta in 
Dopaminergic Neurons to Induce Cell Death: Relevance to Epigenetic Mechanisms 
of Neurodegeneration in Parkinson's Disease. The Journal of biological chemistry. 
Kanai T, Seki S, Jenks JA, Kohli A, Kawli T, Martin DP, Snyder M, Bacchetta R, Nadeau 
KC (2014) Identification of STAT5A and STAT5B target genes in human T cells. 
miR oxidative stress 9:e86790. 
Kanthasamy AG, Kitazawa M, Kanthasamy A, Anantharam V (2003) Role of proteolytic 
activation of protein kinase Cdelta in oxidative stress-induced apoptosis. Antioxid 
Redox Signal 5:609-620. 
Kaul S, Kanthasamy A, Kitazawa M, Anantharam V, Kanthasamy AG (2003) Caspase-3 
dependent proteolytic activation of protein kinase C delta mediates and regulates 1-
methyl-4-phenylpyridinium (MPP+)-induced apoptotic cell death in dopaminergic 
cells: relevance to oxidative stress in dopaminergic degeneration. Eur J Neurosci 
18:1387-1401. 
Latchoumycandane C, Anantharam V, Jin H, Kanthasamy A, Kanthasamy A (2011) 
Dopaminergic neurotoxicant 6-OHDA induces oxidative damage through proteolytic 
activation of PKCdelta in cell culture and animal models of Parkinson's disease. 
Toxicology and applied pharmacology 256:314-323. 
95 
 
Michalke B, Fernsebner K (2014) New insights into manganese toxicity and speciation. J 
Trace Elem Med Biol 28:106-116. 
Paukku K, Silvennoinen O (2004) STATs as critical mediators of signal transduction and 
transcription: lessons learned from STAT5. Cytokine & growth factor reviews 
15:435-455. 
Ramos HL, O'Shea JJ, Watford WT (2007) STAT5 isoforms: controversies and 
clarifications. Biochem J 404:e1-2. 
Tan SH, Nevalainen MT (2008) Signal transducer and activator of transcription 5A/B in 
prostate and breast cancers. Endocr Relat Cancer 15:367-390. 
Wang D, Moriggl R, Stravopodis D, Carpino N, Marine JC, Teglund S, Feng J, Ihle JN 
(2000) A small amphipathic alpha-helical region is required for transcriptional 
activities and proteasome-dependent turnover of the tyrosine-phosphorylated STAT5. 
EMBO J 19:392-399. 
Williams KC, Renthal NE, Condon JC, Gerard RD, Mendelson CR (2012) MicroRNA-200a 
serves a key role in the decline of progesterone receptor function leading to term and 
preterm labor. Proc Natl Acad Sci U S A 109:7529-7534. 
Zheng W, Fu SX, Dydak U, Cowan DM (2011) Biomarkers of manganese intoxication. 
Neurotoxicology 32:1-8. 
 
96 
 
 
A)
Con Mn
β-Actin
300 µM Mn, 0%FBS
β-Actin
STAT5b
STAT1
pSTAT5b Y699
B)
Co
n Mn Co
n Mn
0
25
50
75
100
125
150
STAT5b
pSTAT5b Y699**
**
Ex
pr
es
si
on
 o
f S
TA
T5
b
(%
  C
on
tr
ol
)
C)
Con Mn
ST
AT
5b
Ho
ec
hs
t
M
er
ge
Con Mn
0
20
40
60
80
100
120
(12hr 300µM)
**
ST
AT
5b
 m
R
N
A
ex
pr
es
si
on
(%
 C
on
tr
ol
)
D)
 
Fig. 1. Manganese (Mn) induces STAT5B downregulation in dopaminergic neuronal 
cells. N27 dopaminergic neuronal cells were exposed to Mn. Expression of STATs was 
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measured by Western blot (A) and their densitometric analyses (B). Quantitative expression 
of STAT5B mRNA post-Mn exposure (C). Intracellular localization of STAT5B post-Mn 
exposure. Asterisks, **p<0.01 for control versus Mn-treated group. The results are 
represented as the mean ±S.E.M. of three individual replicates of experiments. 
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Fig. 2. Time- and dose-dependent downregulation of STAT5B. N27 dopaminergic 
neuronal cells were exposed to 300µM Mn at various time points (A). Mouse embryonic 
primary striatal cells were exposed to various concentration of Mn (C). Densitometric 
analyses (B and D). Asterisks, **p<0.01, and ***p<0.001 for control versus Mn-treated 
group. The results represent the mean ±S.E.M. of three individual replicates of experiments. 
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Fig. 3. Manganese induces downregulation of STAT5B pathway. N27 cells were exposed 
to various concentrations of Mn. Expression of the STAT5B downstream target Bcl-2(A) and 
densitometric analysis ofBcl-2 expression after 300µM Mn (B). To assess the role of 
proteasome in downregulation of STAT5B, cells were pre-treated with lactacyst in prior to 
300µM Mn exposure (C). Densitometric analysis after lactacystin and Mn (D). Asterisks, 
*p<0.05 for control versus Mn-treated group. The results represent the mean ±S.E.M. of 
three individual replicates of experiments. 
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Fig. 4. Oxidative stress induces STAT5B downregulation during Mn exposure. N27 
dopaminergic neuronal cells were pre-treated with the anti-oxidative stress agentN-Acetyl 
Cysteine (NAC) prior to 300µM Mn. STAT5B expression was examined in Western blot (A) 
and its densitometric analysis (B). The oxidative stress inducer MPP+ was administered to 
N27 cells and STAT5B expression was measured by Western blot (C) and its densitometric 
analysis (D). Asterisks, *p<0.05 and **p<0.01 for control versus Mn-treated group. The 
results represent the mean ±S.E.M. of three individual replicates of experiments. 
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Fig. 5. Overexpression of STAT5B protects N27 dopaminergic neuronal cells from Mn 
exposure. Cell viability was measured in MTS assay (A). Bcl-2 expression was measured in 
STAT5B-overexpressed N27 cells (B) and its densitometric analysis (C). Asterisks, *p<0.05 
and ***p<0.001 for control versus Mn-treated group. The results represent the mean ±S.E.M. 
of three individual replicates of experiments. 
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Fig. 6. Overexpression of STAT5B protects mitochondria from Mn-induced toxicity. 
Mitochondria were visualized in N27 dopaminergic neuronal cells overexpressing STAT5B 
during a 300 µM Mn exposure (A) for quantifyingmitochondrial length (B), degree of 
circularity (C) and mitochondrial DNA replication (D). Asterisks, *p<0.05 for control versus 
Mn-treated group. The results represent the mean ±S.E.M. of three individual replicates of 
experiments. 
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Fig. 7. Expression of STAT5B was suppressed in an in vivo model of Mn-induced 
neurotoxicity. Scheme of Mn treatment to C57 black mice (A).Expression of STAT5B in the 
substantia nigra in Mn-treated group (B) and its densitometric analysis (C). Asterisks, 
*p<0.05 for control versus Mn-treated group. The results represent the mean ±S.E.M. of 
three individual replicates of experiments. 
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Fig. 8. Expression of STAT5B was suppressed in an in vivo model of MPTP-induced 
neurotoxicity. Scheme of MPTP treatment of C57 black mice (A). Expression of STAT5B 
in substantia nigra (B) and its densitometric analysis (C). Asterisks, **p<0.01 for control 
versus MPTP-treated group. The results represent the mean ±S.E.M. of three individual 
replicates of experiments. 
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Fig. 9. Expression of STAT5B was suppressed in the MitopPark mouse model of PD. 
Expression of STAT5B in substantia nigra of 25-wk-old MitoPark mice (A) and its 
densitometric analysis (B). Asterisks, *p<0.05 for control versus MitoPark mice. The results 
represent the mean ±S.E.M. of three individual replicates of experiments. 
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Fig. 10. Manganese induces suppression of STAT5B promoter activity. Scheme of 
promoter activity reporter system (A). STAT5B promoter from 1000 upstream to 500 
downstream was cloned into luciferase reporter system. STAT5B promoter during Mn 
exposure was measured and quantified (B). Asterisks, ***p<0.001 for control versus Mn-
treated group. The results represent the mean ±S.E.M. of three individual replicates of 
experiments. 
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Fig. 11. Manganese exposure downregulates STAT5Bexpression in human lymphocytes. 
Expression of STAT5B was measured in Western blot for Mn-induced cytotoxicity in human 
lymphocytes (A) and in its densitometric analysis (B). Asterisks, *p<0.05 for control versus 
Mn-treated group. The results represent the mean ±S.E.M. of three individual replicates of 
experiments. 
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Abstract 
Chronic exposure to an elevated level of manganese (Mn) has been linked environmentally to 
Parkinson’s disease-like neurological abnormalities. We previously found that Mn exposure 
selectively downregulated the neuroprotective signal transducer and transcription activator 5b 
(STAT5B). To characterize the molecular mechanisms underlying STAT5B downregulation in Mn-
induced neurotoxicity, the STAT5B promoter was used to examine the effects of 300 μM Mn 
exposure to MN9D dopaminergic neurons. Promoter analyses revealed that a proximal promoter 
region near exon 1 contains the regulatory element responsible for the response to Mn exposure to 
control STAT5B transcription. Detailed site-directed mutational analyses of the putative transcription 
factor binding sites showed that Sp1 like transcription factor binding sites in the promoter region 
containing exon 1 may be required for the suppression of STAT5B in Mn-induced neurotoxicity. Two 
KLF binding sites exhibited inducible transcription repression of STAT5B with Mn exposure, 
whereas one Sp1 binding site exhibited transcription activation by sensing Mn exposure and reducing 
its activity. Taken together, these data suggest Mn exposure alters the activities of transcription 
factors to suppress the transcription of anti-apoptotic STAT5B via an Sp1-like transcription factor-
dependent mechanism in dopaminergic neurons, which may significantly contribute to Mn 
neurotoxicity. (NIH grants ES10586, ES19267, and NS74443).  
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1. Introduction 
Advancement of overall biomedical technology and sciences in the contemporary era 
increased not only the quality of life but also increased life expectancy. Consequently, an 
increased elderly population leads more prevalence of neurodegenerative diseases in societies 
(Duncan, 2011).  
Parkinson’s disease (PD) is the second most prevalent neurodegenerative disease after 
Alzheimer’s disease. Degeneration of dopaminergic neurons in the substantia nigra region 
induces motor-behavioral abnormalities as well as other characteristics such as sleeplessness 
and psychiatric problems. Pathological features include bradykinesia, trembling, rigidity, and 
postural instability. The exact pathological cause of PD still remains elusive (Gupta et al., 
2008, Ben-David and Tu, 2015, Fernandez, 2015).  
Manganese (Mn) is a transition metal which has been used in industry for many years. 
Broad usage of Mn has lead to an increase in human exposure both in industrial settings and 
everyday lives, from the metal alloy industry to anti-fungal drugs and gasoline additives to 
medical equipment (Portier, 2012, Farina et al., 2013, Martinez-Finley et al., 2013). Long 
term exposure to low levels of Mn induces a neurodegenerative disease somewhat similar to 
PD and shares common pathological features, such as loss of dopaminergic neurons in 
midbrain leading to abnormal motor behavioral deficit (Caudle et al., 2012, Racette et al., 
2012, Farina et al., 2013). Manganese-induced neurodegeneration differs from PD in several 
ways including inefficiency of L-DOPA treatment (Guilarte, 2011). Nonetheless, Mn 
exposure plays a very important role in the development of PD, as exposure to Mn expedites 
PD disease progression (Racette et al., 2001, Santamaria et al., 2007). Despite the emphasis 
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on finding key molecules that induce degeneration of dopaminergic neurons, few key 
molecules have been identified to delineate the cellular and molecular mechanisms 
underlying how Mn exposure induces neurodegenerative diseases.  
Signal transducers and activators of transcription (STATs) relays extracellular signals 
and amplify signaling in downstream cascades (Paukku and Silvennoinen, 2004, Tan and 
Nevalainen, 2008). STATs are comprised of 6 family members that share high structural 
homology. Each member of the STAT family has similar or distinct functions. A variety of 
ligands such as growth hormones, interleukins and cytokines can bind and activate Janus 
kinase (JAK)s, which in turn recruits and activates STAT proteins by phosphorylation. The 
homo- or hetero-dimers of phosphorylated STATs are translocated to the nucleus and induces 
transcription of its target genes. Among STATs, STAT5 plays important roles in growth and 
differentiation of several tissues (Buitenhuis et al., 2004, Paukku and Silvennoinen, 2004, 
Abroun et al., 2015). There are two highly homologous STAT5 proteins, STAT5a and 
STAT5B. STAT5B plays important roles in growth and differentiation of lymphocytes and 
development, whereas STAT5a plays a role in development and differentiation of mammary 
gland and female specific gene expressions (Paukku and Silvennoinen, 2004). In spite of 
distinct roles between STAT5a and STAT5B, they share their gene targets and can somewhat 
complement each other when either STAT5a or STAT5B is knocked out.  In previous studies, 
our laboratory found that Mn exposure induces downregulation of STAT5B in neuronal cell 
lines and animal models (unpublished data). STAT5B demonstrated a neuroprotective role 
against Mn-induced neurotoxicity, indicating downregulation of STAT5B sensitized 
neuronal cells to Mn-induced cytotoxicity. Overexpression studies showed that STAT5B has 
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protective effects against to Mn-induced neurotoxicity. Interestingly, we observed the 
suppression of mRNA expression of STAT5B during Mn exposure. Furthermore, we showed 
that Mn exposure suppressed transcription of STAT5B. However, the exact mechanisms of 
how Mn exposure induces downregulation of STAT5B have not been studied. In this study, 
we report that Mn exposure induces alteration of activities of multiple transcription factors to 
control of expression of STAT5B.  
 
2. Materials and Methods 
2.1 Chemicals 
Manganese chloride (MnCl2, 99%) was purchased from Sigma-Aldrich (St. Louis, MO). 
Antibodies against STAT5B and β-Actin were purchased from Santa Cruz Biotechnology (Santa Cruz, 
CA). Bradford protein assay kit was purchased from Bio-Rad Laboratories (Hercules, CA). The anti-
mouse and anti-rabbit secondary antibodies (Alexa Fluor 680 conjugated anti-mouse IgG and IRdye 
800 conjugated anti-rabbit IgG) were purchased from Life Technologies (Grand Island, NY) and 
Rockland (Gilbertsville, PA), respectively. DMEM powder was purchased from Sigma-Aldrich (St. 
Louis, MO). Fetal bovine serum, L-glutamine, penicillin, and streptomycin were purchased from Life 
Technologies. CellTiter® 96 AQueous Assay and Nano-Glo® Luciferase assay system were 
purchased from Promega (Madison, WI).  
Cell cultures and treatment 
MN9D, a mouse-derived dopaminergic neuronal cell line, were maintained in DMEM media 
supplemented with 10% fetal bovine serum, 2mM L-glutamine, 50 units of penicillin, and 50µg/ml of 
streptomycin in a humidified incubator with 5% CO2 at 37°C as described previously (Jin et al., 2011, 
Latchoumycandane et al., 2011). After exposing Mn9D cells to designated concentrations of Mn for 9 
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h, the cells were subjected to quantitative real-time RT-PCR or western blot analysis.  
Plasmid constructs 
Nucleotide sequence information of STAT5B promoter was obtained from NCBI. DNA from 
the brain of  C57 black mice was isolated using DNeasy miniprep kit (Qiagen) and used as template 
to amplify the promoter region of STAT5B. In order to clone the promoter regions, primers were 
designed to bind to the specific location of promoters as depicted in the figures and contain restriction 
enzyme sequence either Nhe I or Kpn I with extra sequences. Primer sequences will be available upon 
request. The PCR amplicon were digested with proper restriction enzyme before ligated to pNL1.1 
NanoLuc®Luciferase vector (Promega). All cloned promoter region of STAT5B were sequenced and 
confirmed. Site-directed mutageneses were performed to generate deletion mutant of putative 
transcription factor binding site. Briefly, mutagenic forward primers were designed to bind to the 
nucleotide sequence just after deletion site and amplified partial promoter region with reverse primer 
which bind to vector backbone. Similarly, mutagenic reverse primers were designed to bind to the 
nucleotide sequence just before deletion site and amplified partial promoter region with forward 
primer which bind to vector backbone. The resulting two PCR amplicons were used as template to 
generate full length promoter with two vector backbone primers. The final PCR amplicons were 
digested to proper restriction enzymes and ligated to pNL 1.1 Nano Luc®Luciferase vector. Each 
deletion mutant of STAT5B promoter 1 was sequenced and confirmed. 
Promoter activity assay 
Mn9D cells were transfected with luciferase reporter vector fused with either STAT5B 
promoter or empty vector together with lacZ vector 24h prior to exposure to Mn using 
lipofectamine2000 (Life Sciences). Treated cells were collected and lysed with lysis buffer (Promega), 
followed by luciferase assay (Promega) for the measurement of luciferase activity using Nano-glo® 
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Luciferase assay system (Promega). Cell lysates were further analyzed for β-galactosidase activity 
which was used for normalization.   
Transfections 
Mn9D cells were transfected with 10ug of promoter reporter vector or promoter reporter 
vector expressing STAT5B promoter with luciferase by using lipofectamine2000 reagent 
(Lifescience) according to manufacturer's protocol. Transfected cells were seeded in 12 well plates 
for promoter analysis, T-25 flasks for quantitative RT-PCR, or 96-well plates for cell proliferation 
assays before the treatment next day.  
Cell proliferation assays 
Cell survival was measured by colorimetric MTS assay (CellTiter® 96 AQueous Assay). 
Cells were seeded in 96-well plates before exposure to Mn. At the end of treatment, 20% MTS 
reagent was added to each well. The MTS tetrazolium compound is bioreduced in living cells to its 
colored formazan products. After incubating for up to an hour, absorbance at 490nm was measured 
using SpectraMax spectrophotometric plate reader (Molecular Devices). 
Quantitative RT-PCR 
After treatment, total RNA was extracted from cells or tissues using an Absolutely RNA Mini 
Extraction Kit (Agilent Technologies, Santa Clara, CA) according to manufacturer's protocol. 
Complementary DNAs were prepared with DNase I treatment using the High Capacity cDNA 
Synthesis Kit (Life Technology, Grand Island, NY).SYBR Green quantitative PCR was performed. 
Forward primer (5'- GCAATGATTATAGCGGCGAGA-3') and reverse primer (5'- 
CAAAGGCGTTGTCCCAGAGG-3') were used for detection of STAT5B mRNA. Primers for 18S RNA 
(Qiagen) were used as housekeeping gene control for normalization. The threshold cycle (Ct) was 
calculated from the instrument software, and fold change of gene expression for pair-wise 
comparisons was calculated using the ∆∆Ct method.  
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In silico analysis for putative transcription factors 
Putative regulatory promoter region were scanned to predict putative transcription factor 
binding sites with the Genomtix suit: http://www.genomatix.de/. 
Statistical analysis 
Data were analyzed using Prism 4.0 software (GraphPad Software, San Diego, CA). Paired 
Student t-test were performed. Tukey's multiple comparison test was used after ANOVA for 
comparing differences between multiple groups. Differences were considered statistically significant 
if p-values < 0.05 were obtained. Data are represented as the mean ± S.E.M. of at least two separate 
experiments performed at least in triplicate. 
 
3. Results 
3.1 Downregulation of STAT5B of mouse dopaminergic neurons upon Mn-induced 
neurotoxicity 
 We previously showed that Mn exposure compromised STAT5B expression to induce 
cytotoxicity in dopaminergic neuronal system (unpublished data). Mn was shown to reduce 
STAT5B expression at the protein level as well as the mRNA level. To study the effects of 
Mn on the transcriptional suppression on STAT5B gene expression in mouse dopaminergic 
neuronal cells, MN9D cells were used to examine whether Mn exposure induces 
downregulation of STAT5B. Mn exposure at 300 μM dose induced cytotoxicity. The cell 
viability of MN9D cells exposed to 300 μM Mn for 9 h was measured by performing MTS 
assay and showed that Mn exposure induced over 50% toxicity (Fig. 1B). The expression of 
STAT5B at the mRNA level after Mn exposure was measured by performing quantitative 
RT-PCR. The mRNA expression of STAT5B in MN9D cells treated with 300 μM Mn was 
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suppressed more than 40% compared to control, indicating Mn exposure significantly 
compromises STAT5B expression during Mn exposure (Fig. 1C).  
 
3.2 Mn exposure suppresses promoter activity of STAT5B expression in dopaminergic 
neuronal cells 
There are two alternatively spliced isoforms of STAT5B in the mouse, and both 
generate fully functional proteins. This alternative splicing was generated by the use of an 
alternative promoter and first exons with different sizes, respectively (Fig. 2). Although the 
promoter 2 generates an untranslated 519 bp long exon 1 (exon 1’) and encodes the full 
length STAT5B protein, its usage is very limited and reported once in the thymus 
(http://fantom.gsc.riken.jp/3/db/annotate/%20main.cgi?masterid=E430022O15). Unlike 
promoter 2, promoter 1 of mouse STAT5B has been reported extensively and produces an 
untranslated 329bp long exon 1 (exon 1) (Fig. 2). Promoter 1 in mice shares high homology 
with  human STAT5B. Hence, we decided to focus on the promoter 1 of mouse STAT5B to 
study how Mn exposure induces suppression STAT5B transcription. Genomic fragments of 
the mouse STAT5B promoter 1, from 2,000 bp upstream to 500 bp downstream, were cloned 
from C57 black mice as depicted in Fig. 3A and Fig. 4A. The genomic fragments of the 
promoter regions were fused to a Luciferase promoter reporter vector, pNL1.1.  
To study Mn-induced suppression of the STAT5B promoter, we first analyzed the 
promoter activity of different 250 bp promoter regions by location (Fig. 3A). The 250 bp 
promoter fragments starting -2000 bp upstream of STAT5B exon1 to +500 bp downstream 
were cloned into the pNL1.1 as depicted in Fig 3A. The genomic fragments of the promoter 
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were sequenced and validated with the information of the nucleotide sequences of the mouse 
STAT5B promoter 1 obtained from NCBI webpage. Primers were designed to bind to each 
promoter fragment Promoter-reporter systems were transfected into MN9D cells containing 
either empty vector or the STAT5B promoter fragments, followed by exposure to 300µM Mn 
for 9 h. The proximal promoter showed stronger transcriptional activity compared to the 
distal promoter region of the STAT5B promoter in both control cells and Mn exposed cells. 
Specifically, the promoter region from 250 bp upstream to 500 bp downstream of exon 1 
showed strong transcriptional activity, whereas the region between -500 bp upstream to -250 
bp showed less promoter activity. However, proximal regions between 250 bp upstream to 
250 bp downstream showed strong repression of the promoter during exposure to Mn. Next, 
we examined whether Mn exposure induces synergistic effects in suppressing promoter 
activity in transcription of STAT5B. We subcloned a series of various promoter regions of 
different length (Fig. 4A). The longer region of the promoter did not strengthen promoter 
activity compared to the shorter proximal region of promoter (Fig. 4B). Inclusion of the 500 
bp upstream to 250 bp upstream region greatly repressed promoter activity. As the genomic 
fragment from 500 bp to 250 bp upstream region demonstrated highly repressed promoter 
activity and addition of the region into the longer genomic regions from 500 bp upstream to 
500 bp downstream repressed the promoter activity, this region may have repressive 
elements controlling the expression of STAT5B. Addition of the upstream region of the 
promoter, above 500 bp upstream, did not further reduce promoter activity which also 
supports the hypothesis that the genomic fragment from 500 bp upstream to 250 bp upstream 
may contain transcription repressive element. The longer distal promoter regions from 2000 
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bp upstream to 1000 bp upstream did not appear to have strong promoter activity of STAT5B 
transcription. Mn exposure repressed the promoter activity in most promoter regions. 
However, it was the promoter region from exon 1 to 00 bp downstream that showed strong 
repressive effects by Mn exposure compared to control. Addition of all other regions did not 
induce additive repressive effects in promoter activity. These results suggest that the promote 
regions from exon 1 to 500 bp downstream may have accumulative effects in repression of 
promoter activity, implying the Mn exposure-responsive and sensitive repressive elements 
may exist in this region. Interestingly, the region containing strong general repressive 
element did not show repressive effects by Mn exposure, suggesting this region may be 
activated by other mechanisms.  
 
3.3 Repressor responds to Mn exposure to suppress STAT5B transcription 
To identify putative transcription factors that bind to the STAT5B promoter, we used 
genomatix suit software to perform in silico analysis of the proximal region from 250 bp 
upstream to 500 bp downstream of exon 1, which appears to have Mn exposure-responsive 
elements. Among the in silico potential transcription factors, only transcriptions factors 
which have been reported to bind to STAT5B and those that have scores higher than 0.95 
were selected (Fig 5). The binding site of each potential transcription factor was deleted via 
site-directed mutagenesis in order to validate whether the putative transcription factors were 
able to bind to the selected region of STAT5B promoter 1 and respond to Mn exposure to 
regulate the expression of STAT5B. The promoter regions were fused to a luciferase reporter 
system containing STAT5B promoter 1 with either a mutant binding site or wild type and 
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then were transfected into MN9D cells before exposure to 300 µM Mn. We found that mouse 
KLF and KLF7 play a role in STAT5B transcriptional repression in normal condition (Fig. 6 
A and C). A mouse KLF binding site is located within exon 1, and deletion of this binding 
site in the promoter induced stronger transcription activity, indicating that this factor may 
play a role as a transcription repressor (Fig. 6 A). Surprisingly, 300µM Mn exposure failed to 
repress transcriptional activation of the STAT5B promoter 1. Another putative transcription 
factor is SP1 and an SP1 binding site is present within exon 1 (Fig 6. B). Deletion of this SP1 
binding site significantly reduced transcriptional activity, to roughly 50% in the absence of 
Mn exposure compared to wild type control, indicating SP1 may play a role as a  
transcriptional activator. Mn exposure of 300 µM further reduced transcriptional activity 
from the already reduced transcriptional activity due to the deletion of binding site of SP1. 
However, the reduction of transcription activity of the deletion mutant over the control in the 
absence of Mn exposure was less than the reduction of transcriptional activity in wild type. 
This may imply that the role of SP1 as a potential transcriptional activator may be reduced in 
the presence of Mn exposure. Another putative transcription factor located in intron 1 is 
KLF7 (Fig 6. C). Deletion of the KLF7 binding site did not affect the transcriptional activity 
on STAT5B promoter 1 in the absence of Mn exposure. However, when neuronal cells were 
exposed to Mn, KLF7 deletion mutant showed higher activity than the transcription activity 
of wild type. These results indicate that two KLF7 transcription factors may sense the Mn 
exposure and work as transcription repressors in the presence of Mn exposure. Sp1 
transcription factor binding to the promoter region in exon 1 may also have a role as 
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transcription activator. This Sp1 transcription factor may become less active during Mn 
exposure. 
 
4. Discussion 
Overexposure of Mn in neurons results in cytotoxic cell death leading to the 
development of neurodegenerative diseases that shows similar clinical symptoms like that of 
PD (Bowman et al., 2011, Caudle et al., 2012, Farina et al., 2013). It has been known that 
STAT5B potentially facilitates cell growth and also protects the cells against multiple stress 
scenarios and toxicity (Du et al., Buitenhuis et al., 2004, Paukku and Silvennoinen, 2004, 
Tan and Nevalainen, 2008, Han et al., 2009, Cholez et al., 2012, Kalita et al., 2013, Abroun 
et al., 2015). We have recently observed that there was significant downregulation of 
STAT5B in the neurons post exposure to Mn (unpublished data). This present study provides 
a vivid evidence on the down regulatory effects of Mn exposure on STAT5B by modulation 
of transcriptional factors in neurons.  
For understanding the mechanisms of Mn-induced downregulation of STAT5B, an in 
vitro neuronal cell culture model was employed using the Mn9D mouse dopaminergic 
neuronal cells.. Exposure of Mn9D neuronal cells to 300 μM Mn for 9 h induced a 
neurotoxic cell death.(Fig. 1A). It was also observed that STAT5B mRNA expression was 
downregulated in MN9D cells post the Mn exposure (Fig. 1B). These results coherently 
consistent with our recent findings on the N27 rat dopaminergic neuronal cells, showing  
downregulation of STAT5B prior to exposure with 300 μM Mn (unpublished data).  
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The mouse model commonly expresses two alternative splicing forms of STAT5B 
with two different promoters. Major splice form of STAT5B uses promoter 1 which was 
identified and reported in multiple organs (Fig. 2). Whereas the promoter 2 corresponding to 
the mouse STAT5B has been reported by a Japanese group only once in the thymus tissue 
(unpublished data). Interestingly it has been shown earlier that promoter 1 of STAT5B shares 
a high homology between human, mouse and rat(Crispi et al., 2004). Henceforth we have 
employed the mouse STAT5B for our studies.  
The promoter studies performed at different locations using 250 bp genomic 
fragments of STAT5B promoter showed that the proximal location of the promoter contains 
strong promoter activity (Fig. 3). Moreover, the proximal promoter region indicated the 
strongest promoter activity, confirming that transcription activators may bind in the proximal 
region near to exon 1. Also, a sudden reduction of promoter activity was observed at 500 bp 
upstream indicating that the 500 bp upstream region might contain repressor activity. Mn 
exposure suppressed the transcriptional STAT5B expression throughout location of 
promoters. This in addition may indicate that Mn exposure might be involved in suppression 
of overall transcriptional activity of STAT5B in a wide range of promoter regions. However, 
proximal promoters near exon 1 were shown to be more sensitive to Mn exposure in 
reduction of transcriptional activities.    
Differential length of STAT5B promoter was examined to study whether Mn 
exposure induces synergistic effects in suppressing transcription of STAT5B (Fig. 4). 
Surprisingly, the transcriptional activities did not show additive effects in activating 
transcription. Whereas, the combining of proximal promoter regions from 500 upstream to 
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500 downstream showed less transcriptional activity compared to 250 bp downstream 
promoter region. Alternatively, it could be interpreted that transcription repressor regulated 
the transcription of STAT5B. Further analysis of longer fragments of STAT5B promoter 
showed lesser transcriptional activity. As a result, we were driven to suggest that multiple 
transcription repressors when compared to longer range of promoter region might be 
involved in regulation of transcriptional activation and repression in the expression of 
STAT5B. Note-worthily, promoter region from exon 1 to 500 bp downstream is revealed to 
have an accumulative effect in repressing promoter activities during Mn exposure. This 
repressive effect of promoter region 500 upstream to 250 upstream did not limit  further from 
basal repressive effects. These cumulative results suggest that the transcription factorss that 
can sense Mn exposure and regulate STAT5B transcription might be present in exon 1 and in 
the downstream region. 
The in silico analyses performed with Genomatix suites showed the putative binding 
of TFs to the promoter 1. TATA and CAAT box were not found in the promoter 1, whereas 
exon 1 contained a high GC content and many more TF binding sites such as zinc finger TF 
and SP1 binding sites. Human STAT5B promoter does not have a TATA and also a CAAT 
box but  contains multiple SP1 sites (Crispi et al., 2004). Thus it is possible that the 
mechanisms in response to Mn exposure to regulate mouse STAT5B expression, may also 
apply for humans . As seen from our results the mouse KLF binds to the promoter region at 
41 bp of exon 1 (Fig. 6 A). Site-directed deletion mutant of this binding site of mouse KLF 
does not affect basal transcriptional activity in the absence of Mn. However, the 
transcriptional activity of this deletion mutant was almost not repressed during Mn exposure, 
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thereby indicating that the mouse KLF suppresses transcription only in the presence of Mn. 
Surprisingly, another putative TF binding site for KLF7, was present in the downstream of 
exon 1 (Fig. 6 C). Like as in the mouse KLF, the deletion of this binding site for KLF7 did 
not harm the basal transcriptional activity. However, deletion of KLF7 binding sites 
compromised the reduction post Mn exposure. Interestingly, one SP1 present in exon 1 
functioning as a transcriptional activator was identified to be sensitive to Mn treatment which 
further induced reduction of transcriptional activation with Mn treatment. It was not very 
surprising that SP1 was sensitive to Mn exposure and also that it regulates the expression of 
STAT5B. This is because SP1 has been shown previously  to be sensitive and also that it gets 
activated during Mn exposure to induce upregulation of caspase-3 transcription (Uchida et al., 
2012). It has also been reported that Sp1 acts as transcription repressor with histone 
deacetylase (Kaczynski et al., 2001).  Collectively these data suggest that  Mn exposure alters 
activities of TF to regulate STAT5B transcription. 
In conclusion, this report demonstrates that Mn exposure reduced STAT5B expression at the 
mRNA level and alters the activities of TFs to downregulate transcription of STAT5B in 
dopaminergic neuronal cells. Also interestingly, Sp1 acts as a transcription activator sensitive 
to Mn exposure, whereas KLF plays the function as a transcription repressor. 
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Fig. 1. Manganese (Mn) induces downregulation of STAT5B in dopaminergic neuronal 
cells. Mouse dopaminergic neuronal cells, Mn9D, were exposed to 300µM Mn for 9h. MTS 
assay was performed to measure Mn induced cytotoxicity (A). Quantitative expression of 
STAT5B was measured at mRNA level post exposure to Mn (C). Asterics *p<0.05 for 
control versus Mn-treated group. The results represent the mean S. E. of three individual 
replicates of experiments.  
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Fig. 2. Schematic presentation of mouse STAT5B promoter. Translated exons were 
represented with blue box, whereas untranslated exon was represented with grey box. Introns 
were represented with line. STAT5B promoter 1 region from 2,000 bp upstream to 500nt 
downstream was cloned for further promoter analyses. Subcloned STAT5B promoter was 
fused to Luciferase reporter system. 
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Fig. 3. Analyses of STAT5B promoter 1 in different location during Mn exposure. 
STAT5B promoter 1 regions with 500 bp was subcloned and subsequently fused to luciferase 
reporter system (A). STAT5B Promoters fused to luciferase reporter system were transfected 
to Mn9D dopaminergic neuronal cells. After 300 µM Mn exposure for 9h, promoter activities 
were measured via luminescence (B). Asterics *p<0.05 for control versus Mn-treated group. 
The results represent the mean S. E. of three individual replicates of experiments. 
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Fig. 4. Analyses of diffential length of STAT5B promoter 1 during Mn exposure. 
STAT5B promoter 1 was subcloned in differential length from downstream of exon 1 (A). 
STAT5B Promoters fused to luciferase reporter system were transfected to Mn9D 
dopaminergic neuronal cells. After 300 µM Mn exposure for 9h, promoter activities were 
measured via luminescence (B). Asterics *p<0.05 for control versus Mn-treated group. The 
results represent the mean S. E. of three individual replicates of experiments. 
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Fig. 5. In silico analysys of potential transcription factors binding to proximal region of 
STAT5B promoter 1. Potential transcription factors of STAT5B promoter 1 from 250 bp 
upstream to 500 bp downstream encompassing exon 1 were searched through MatInspector 
from Genomatix suites. Transcription factors either with experimental evidence or high score 
over 0.95 were shown. 
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Fig. 6. Transcription factors repress transcriptional expression of STAT5B during Mn 
exposure. Transcription factor binding sites were deleted via site-directed mutagenesis (left 
panels of A, B and C). Red box denotes the sites of deletion of TF binding sites. Either wild 
type or deletion mutant of transcription factor binding sites were transfected to Mn9D cells 
1day before exposed to 300 µM Mn for 9h. Promoter activities were measured via 
luminescence (middle panels of A, B and C). Promoter activities of either wild type or 
deletion mutant were compared to control group (% of control). Asterics ***p<0.001 and 
*p<0.05 for control versus Mn-treated group. The results represent the mean S. E. of three 
individual replicates of experiments.  
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CHAPTER V: GENERAL CONCLUSIONS 
This section presents an overview of the results and findings of this dissertation, with 
a special emphasis on overall implications of these findings for developing novel 
neuroprotective strategies for Parkinson’s disease. The major findings of each research 
chapter included in this dissertation are covered in the discussion section of the relevant 
chapter.  
p73 gene is highly susceptible to Mn induced neurotoxicity in Dopaminergic Neurons 
 
The major finding from Chapter 2 of the thesis is that we identified the p73 genes 
which is sensitive to Mn exposure and play an important role in Mn-induced neurotoxicity in 
nigrostriatal system. To our knowledge this finding is the first evidence that Mn exerts its 
neurotoxic effects by suppressing the expression of the anti-apptotic ΔNp73 protein. A few 
of key molecules that can mediate Mn exposure to dopaminergic neuronal cell death have 
been identified including PKCd, Caspase-3, Caspase-9, YY1, and p53 (Anantharam et al., 
2004, Latchoumycandane et al., 2005b, Yang et al., 2007, Zhang et al., 2007b, Jin et al., 2011, 
Jin et al., 2014, Karki et al., 2014, Wan et al., 2014, Ma et al., 2015). Despite of the 
breakthrough findings of these key molecules, the exact molecular and cellular mechanisms 
underlying Mn-induced neurotoxicity remain elusive. The analyses of the expression of 84 
apoptotic genes in SN of mice treated with 10 mg/kg for 30 days revealed several key 
molecules such as Bok, TNFRSF1a, and p73. The p73 protein was shown to play important 
roles in a wide variety of cellular events including cell death, self-renewal of neural stem 
cells, cell cycle regulation, differentiation of neurons, surveillance of damaged (Yang et al., 
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2002, Ozaki et al., 2005, Killick et al., 2011, Grespi and Melino, 2012, Di et al., 2013, 
Jancalek, 2014, Engelmann et al., 2015, Sabapathy, 2015). p73 gene was shown to be 
implicated in neuronal development, tumor, and neurodegeneration (Grespi and Melino, 
2012, Jancalek, 2014). Two classes of p73 protein producs, TAp73 containing transactivation 
domain and ΔNp73 lacking transactivation domain, antagonize each other.  From the 
following in vivo experiment in which C57 black mice were orally exposed to 30 mg/kg for 
30 days via gavage, the results of PCR array system were validated. Biochemical analyses of 
SN revealed ΔNp73 was downregulated in Mn induced neurotoxicity. Further 
characterization of p73 in Mn-induced neurotoxicity was performed using N27 dopaminergic 
neuronal cells. The in vitro studies showed consistent results that ΔNp73 was downregulated 
in dopaminergic neuronal cell system. The downregulation of ΔNp73 was shown to be time-
dependent and dose-dependent manner in N27 cells and mouse primary striatal cells. The 
results of downregulation of Bcl-xL and Mcl-1, downstream effector molecules of p73 
pathway, indicated that Mn exposure suppresses ΔNp73 pathway. We also showed that 
downregulation of ΔNp73 is independent of activated Caspase-3, as pre-treatment of z-
DEVD-fmk failed to rescue ΔNp73 from Mn-induced neurotoxicity. Finally, we showed that 
ΔNp73 was anti-apoptotic against Mn-induced neurotoxicity. We overexpressed ΔNp73 in 
N27 dopaminergic neuronal cells and performed cell viability assay which revealed that 
ΔNp73 can protect N27 cells from Mn-induced neurotoxicity at lower Mn dose ranging 100 
to 200 μM. Taken together, we demonstrated that ΔNp73 is anti-apoptotic and was 
compromised during Mn exposure. These observations provide new insights into the 
mechanisms underlying Mn-induced dopaminergic neurotoxicity.  
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Mn exposure downregulates neuroprotective STAT5B in dopaminergic neurons 
The major findings in Chapter 3 were the identification of another key molecule, 
STAT5B, that plays a neuroprotective role in dopaminergic neuronal system during Mn 
exposure. This finding came across in the course of identifying the downstream targets of 
PKCd in Mn-induced neurotoxicity. Protein PKC delta was previously shown in our 
laboratory to play important roles in Mn-induced neurotoxicity (Kitazawa et al., 2005, 
Latchoumycandane et al., 2005b, Zhang et al., 2007b, Afeseh Ngwa et al., 2011, Jin et al., 
2014). Interestingly, we found that expression of STAT1 was not greatly altered during Mn 
exposure, suggesting that Mn exposure selectively induces downregulation of STAT5B. We 
characterized the downregulation of STAT5B in Mn-induced neurotoxicity. STAT5B was 
downregulated in time and dose dependent during Mn exposure. Mouse dopaminergic 
neuronal cell, MN9D, and mouse primary striatal culture also showed downregulation of 
STAT5B. STAT5a was shown to be sensitive to proteasomal degradation pathway (Wang et 
al., 2000). We used lactacystin, an inhibitor to proteasomal degradation pathway, to answer 
whether STAT5B may be degraded via proteasomal degradation pathway. The results from 
the studies with lactacystin pre-treatment showed that downregulation of STAT5B from Mn-
induced neurotoxicity was independent of proteasomal degradation pathway. The plausible 
mechanism behind downregulation of STAT5B came from the studies with anti-oxidant drug, 
which showed that pre-treatment of NAC prevented downregulation of STAT5B against Mn-
induced neurotoxicity. MPP+ is neuotoxicant that selectively inhibit dopaminergic neurons 
and generate excessive ROS. Exposure to MPP+ also reduced STAT5B expression, 
supporting the hypothesis that Mn exposure induces excessive oxidative stress which in turn 
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downregulate STAT5B expression. We also characterized the role of STAT5B in Mn-
induced neurotoxicity in dopaminergic neurons and found that STAT5B plays a role of 
protecting the neurons against Mn exposure. We overexpressed STAT5B in N27 cells and 
challenged Mn exposure. The results showed that overexpression of STAT5B protected N27 
cells against Mn exposure. The findings that Mn exposure induces downregulation of 
STAT5B were also encapitulated in in vivo animal model. C57 black mice were exposed to 
30 mg/kg Mn for 30 days.  The expression of STAT5B was downregulated in SN of the Mn 
treated C57 black mice compared to the control group. We further examined the MitoPark 
PD mouse model. We found that STAT5B expression was downregulated in SN of 25wk old 
MitoPark mice. These data are novel findings and provide potential drug candidate for 
neurodegenerative disease which involves oxidative stress. We show that Mn exposure 
downregulates STAT5B expression in human lymphocytes. Taken together, our results 
suggest that Mn exposure downregulates STAT5B in striatal neurons and that Mn-induced 
downregulation of STAT5B may compromise the protective signaling pathway, thereby 
exacerbating neuronal cell death. 
Mn exposure alters profiles of transcription factors to suppress transcription of 
STAT5B in dopaminergic neurons 
In the Chapter 4 we extended mechanistic studies of novel findings from Chapter 3. 
Major findings in chapter 4 were that Mn exposure alters profiles of transcription factors to 
suppress transcription of STAT5B. We subcloned the promoter region of mouse STAT5B 
from 2,000 nt upstream to 500 nt downstream. We subcloned a series of STAT5B promoter 
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regions in different location and differential length of STAT5B promoter regions. From the 
promoter analysis of different location we showed that proximal promoter region of STAT5B 
contained strong transcription activities. These proximal promoter regions were shown to 
contain elements that respond to Mn exposure to repress transcription of STAT5B. Promoter 
studies of differential length of STAT5B promoter region showed that promoter region 
containing exon 1 and proximal downstream region of promoter can synergize the repressive 
effects in repressing the transcription upon Mn exposure. However, the repressive effects 
from distal promoter region was not synergistic to the effects of proximal promoter regions 
of STAT5B. We provided putative transcription factors binding to promoter region from 
exon 1 to 250 nt of downstream region via in silico analysis. Several Sp-1 like factor binding 
sites were identified. Site-deletion mutation of transcription factor binding sites showed that 
two KLFs function as transcription repressor that sense the Mn exposure and activated upon 
Mn exposure. In addition, one Sp1 transcription factor binding site was shown to reduce 
transcription activation during Mn exposure. Taken together, these data suggest Mn exposure 
 
Figure 1. Schematic view of suppression of transcription of STAT5B during Mn exposure 
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alters the profiles of transcription factors to downregulate anti-apoptotic STAT5B signaling 
via Sp1-like transcription factor-dependent mechanism in dopaminergic neurons, which may 
significantly contribute to Mn neurotoxicity.     
In summary, we have identified two neuroprotective genes that are susceptible to Mn 
exposure. Mn exposure suppressed expression of ΔNp73 and STAT5B to exert its 
neurotoxicity. Mn exposure also alters transcription of STAT5B via transcription factors. 
These novel findings may provide important insight in understanding Mn-induced.  
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